Benign neoplasm of meninges

CD2_BENIGN_MENINGES_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D32 Cause of death: ICD-10 — D32 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints CD2_BENIGN_MENINGES_CEREBRAL CD2_BENIGN_MENINGES_SPINAL CD2_BENIGN_MENINGES_NOS	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D10-D36
Name in latin: Neoplasma benignum meningum

NAME	CD2_BENIGN_MENINGES_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_MENINGES_CEREBRAL\|CD2_BENIGN_MENINGES_SPINAL\|CD2_BENIGN_MENINGES_NOS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D32
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D32
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm of meninges based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3841	2886	955
Unadjusted period prevalence (%)	0.84	0.98	0.42
Median age at first event (years)	62.61	61.52	65.92

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3394: Matched controls
33939

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

24.5

323.0

1444

995

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

5795.1

323.0

507

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

4086.5

323.0

376

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

474.4

323.0

1238

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

2365.5

323.0

855

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

6194.3

323.0

536

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

+∞

323.0

1041

H02AB02

ATC

dexamethasone; systemic

80.6

323.0

695

108

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

+∞

323.0

1849

D32.1

ICD-10 Finland

Benign neoplasm: Spinal meninges

2995.5

300.3

286

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

221.6

296.3

303

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

+∞

248.0

235

115

Kela drug reimbursment

Breast cancer

+∞

246.9

234

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

15.4

238.8

409

300

AA1AD

NOMESCO Finland

CT of head and brain

3.5

218.3

1358

5405

PJA12

NOMESCO Finland

Sentinel node biopsy

323.6

210.0

211

N03AX14

ATC

levetiracetam; systemic

15.1

200.7

345

252

D32.06

ICD-10 Finland

Benign tumor of the meninges os petrosum or clivus area

+∞

198.9

189

D32.05

ICD-10 Finland

Cerebral meninges

+∞

193.6

184

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.4

190.3

635

1381

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

7.4

185.1

474

728

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

156.4

182.5

192

WF002

NOMESCO Finland

Radical radiotherapy

142.8

178.3

189

130

Kela drug reimbursment

Malignant tumour

+∞

170.2

162

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.6

165.1

879

2966

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1724.0

164.9

159

D32.03

ICD-10 Finland

Benign meningioma in ventricles

+∞

163.9

156

ABB00

NOMESCO Finland

Excision of lesion of spinal canal

338.8

162.5

163

WX408

NOMESCO Finland

General anesthesy, balanced

3.0

151.7

1123

4786

A04AA02

ATC

granisetron; systemic, transdermal

263.2

148.5

151

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

148.0

141

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

+∞

141.6

135

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

140.6

134

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

13.1

137.3

250

205

ZXC95

NOMESCO Finland

Use of surgical navigator

20.5

132.0

201

104

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

143.7

130.2

138

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

+∞

129.0

123

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

61.8

126.4

148

2252A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Cerebral meninges

+∞

121.6

116

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

12.0

118.3

224

199

N03AF02

ATC

oxcarbazepine; oral

7.8

116.6

283

392

XX3DW

NOMESCO Finland

Time consuming IT work

5.7

116.2

357

682

L02BG04

ATC

letrozole; oral

29.9

115.6

157

WF003

NOMESCO Finland

Adjuvant radiotherapy

393.7

115.2

115

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

1113.7

111.1

108

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.9

110.6

829

3439

C61

ICD-10 Finland

Malignant neoplasm of prostate

231.5

109.3

112

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

550.0

108.4

107

HAC20

NOMESCO Finland

Total mastectomy

156.2

100.7

106

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1007.3

100.6

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

+∞

100.5

L02BA01

ATC

tamoxifen; oral

108.3

96.5

105

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

15.5

94.7

159

107

AA1BD

NOMESCO Finland

Extensive CT of head and brain

9.4

93.9

202

228

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

475.5

93.8

HAB40

NOMESCO Finland

Wedge excision of mammary gland

21.1

93.3

140

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

8.7

90.3

202

244

A03FA01

ATC

metoclopramide; systemic, rectal

2.9

89.6

618

2393

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

9.6

88.9

188

206

L03AA13

ATC

pegfilgrastim; parenteral

+∞

86.8

WX402

NOMESCO Finland

General anaesthesia

2.9

85.6

592

2291

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

106.2

85.3

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

838.4

83.9

WX882

NOMESCO Finland

High dependency care

7.7

82.4

200

275

H53.4

ICD-10 Finland

Visual field defects

7.6

80.7

197

273

9537/0-C70.0

ICD-O-3

Transitional meningioma of cerebral meninges

+∞

80.5

2152

FHL

Extraction, big brain

126.0

80.3

9539/1-C70.0

ICD-O-3

Atypical meningioma of cerebral meninges

+∞

77.4

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

266.5

76.8

XCK00

NOMESCO Finland

Perimetry

3.4

76.7

418

1362

ZX090

NOMESCO Finland

Other technic of radiotherapy

199.4

75.5

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

199.4

75.5

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

78.4

74.4

N03AB02

ATC

phenytoin; systemic

12.7

74.1

135

110

ZXC40

NOMESCO Finland

Use of ultrasound

34.1

71.1

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

127.7

70.1

C50.99

ICD-10 Finland

Breast, unspecified

241.5

69.5

116

Kela drug reimbursment

Prostate cancer

+∞

67.9

R51.80

ICD-10 Finland

Headache

2.5

67.1

625

2842

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.9

67.0

234

510

HA1AA

NOMESCO Finland

X-ray mammography

4.9

66.4

228

488

ZX050

NOMESCO Finland

Stereotactic radiotherapy

105.0

66.1

G40.9

ICD-10 Finland

Epilepsy, unspecified

5.3

65.8

210

414

JN4BD

NOMESCO Finland

Extensive body CT

4.1

65.3

276

725

9530/0-C70.1

ICD-O-3

Meningioma, NOS, of spinal meninges

+∞

64.8

D32

ICD-10 Finland

Benign neoplasm of meninges

+∞

64.8

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

170.7

64.2

WX110

NOMESCO Finland

Local anesthesy

1.9

63.4

2228

17154

R4110

NOMESCO Finland

Physiotherapy

2.1

61.7

935

5302

L01BC06

ATC

capecitabine; oral

+∞

61.6

N02BE01

ATC

paracetamol; systemic, rectal

2.2

61.1

2962

25558

A02BC02

ATC

pantoprazole; systemic

1.9

60.9

2269

17685

22520

ICD-8 Finland

Benign neoplasm of brain and other parts of nervous system, Cerebral meninges

+∞

60.6

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

59.5

9532/0-C70.0

ICD-O-3

Fibrous meningioma of cerebral meninges

+∞

58.5

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.0

58.4

960

5604

WF049

NOMESCO Finland

Radiotherapy of metastasis

+∞

56.4

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

56.4

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

8.2

56.0

129

163

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.2

55.4

679

3494

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.1

54.9

182

374

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

87.3

54.0

N03AF01

ATC

carbamazepine; oral, rectal

3.4

53.1

281

887

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

186.2

53.1

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

62.1

52.5

WF099

NOMESCO Finland

Other radiotherapy

67.7

52.3

N75

ICPC

Benign neoplasm nervous system

269.9

52.3

S18

ICPC

Laceration/cut

1.8

51.8

1386

9495

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

264.5

51.2

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

494.8

49.5

C50

ICD-10 Finland

Malignant neoplasm of breast

253.7

49.2

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

49.1

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

4.1

48.9

199

503

JN4AD

NOMESCO Finland

Body CT examination

4.5

48.9

180

413

N76

ICPC

Neoplasm nervous system unspecified

169.0

48.0

H47.2

ICD-10 Finland

Optic atrophy

22.0

47.1

A04AA55

ATC

palonosetron, combinations; systemic

+∞

47.0

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

47.0

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

46.9

1397

9798

AAK00

NOMESCO Finland

Cranioplasty

103.5

46.9

SPAT1153

SPAT

Removal of sutures

1.8

46.9

1096

7130

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

8.9

46.3

101

117

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

10.8

46.1

XA800

NOMESCO Finland

Neuropsychological investigation

3.9

45.6

197

526

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

65.9

45.2

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

233.0

45.0

X76

ICPC

Malignant neoplasm breast female

233.0

45.0

D33.30

ICD-10 Finland

Acoustic neuroma

11.8

44.9

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

44.9

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

43.8

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

9.3

43.6

101

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

11.8

43.4

A04AA01

ATC

ondansetron; systemic, rectal

4.7

43.4

153

336

L03AA02

ATC

filgrastim; parenteral

39.2

42.9

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

15.2

41.9

NK6AN

NOMESCO Finland

Total body bone isotope imaging

25.0

41.9

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

41.7

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

41.7

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

50.7

41.7

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

40.8

495

2503

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

40.7

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

402.1

40.2

D42.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cerebral meninges

76.1

40.0

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

39.6

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

39.6

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

11.4

39.1

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

12.3

38.8

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.3

38.8

209

666

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

9.0

38.7

C70.0

ICD-10 Finland

Malignant neoplasm: Cerebral meninges

+∞

38.6

H02AB09

ATC

hydrocortisone; systemic

5.1

38.3

124

249

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

72.7

38.0

L02BG03

ATC

anastrozole; oral

103.7

37.8

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

37.6

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.1

37.4

463

2354

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

55.7

37.4

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.3

37.2

382

1788

G40.10

ICD-10 Finland

Simple partial seizures

10.2

37.0

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

36.1

653

3842

TPH07

NOMESCO Finland

Cathetrisation of artery

2.5

36.1

315

1356

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

5.2

36.0

115

227

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

361.0

36.0

D33.02

ICD-10 Finland

Another benign medial tumor of the cerebrum

361.0

36.0

R42

ICD-10 Finland

Dizziness and giddiness

1.7

36.0

842

5389

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

35.5

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

35.5

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

59.2

35.2

D33.45

ICD-10 Finland

Benign Schwannom in the nerve root of the spinal cord

67.3

35.0

ZX070

NOMESCO Finland

Intensity modified radiotherapy

181.8

34.8

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

34.6

337

1533

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

9.2

34.5

8000/0-C70.0

ICD-O-3

Neoplasm, benign of cerebral meninges

+∞

34.4

TAB00

NOMESCO Finland

Lumbar puncture

3.2

33.9

190

623

D33.2

ICD-10 Finland

Benign neoplasm: Brain, unspecified

176.7

33.8

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

5.2

33.4

106

208

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

33.4

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

33.4

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

74.9

32.9

A04AD12

ATC

aprepitant; systemic

171.6

32.7

A79

ICPC

Malignancy NOS

171.6

32.7

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

17.2

32.3

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

319.9

31.9

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

31.3

HAB99

NOMESCO Finland

Other partial excision of mammary gland

8.3

30.7

ZX080

NOMESCO Finland

Image guided radiotherapy

161.4

30.7

WX872

NOMESCO Finland

Intensive care

3.0

30.6

188

657

N03AG01

ATC

valproic acid; systemic, rectal

2.6

30.5

241

980

CS494

NOMESCO Finland

Other visual field testing

4.0

30.5

125

319

Z51.5

ICD-10 Finland

Palliative care

4.3

30.3

116

278

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

30.2

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

30.2

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

30.2

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

83.3

29.8

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

83.3

29.8

L02AE02

ATC

leuprorelin; implant, parenteral

9.3

29.6

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.0

29.5

181

632

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

29.2

B01AB05

ATC

enoxaparin; parenteral

1.6

29.2

910

6253

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

28.9

778

5138

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

44.1

28.7

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

8.7

28.6

H53.2

ICD-10 Finland

Diplopia

3.4

28.3

144

440

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

13.4

28.2

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

28.2

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

28.0

1124

8210

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

27.4

28.0

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

9.5

27.6

N03AX18

ATC

lacosamide; systemic

10.5

27.2

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

27.1

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

27.1

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

27.1

XKD00

NOMESCO Finland

Uroflowmetry

2.0

26.8

367

1932

ZXA05

NOMESCO Finland

Left side

1.6

26.4

838

5763

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

9.8

26.2

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

26.1

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

26.1

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

73.2

25.8

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

262.5

25.7

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

262.5

25.7

L02BB03

ATC

bicalutamide; oral

262.5

25.7

128

Kela drug reimbursment

Cancers of female genital organs

262.5

25.7

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

25.7

525

3179

Y77

ICPC

Malignant neoplasm prostate

94.1

25.7

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.8

25.5

171

631

N05CF01

ATC

zopiclone; oral

1.5

25.3

1083

7983

ZZR00

NOMESCO Finland

Flap of skin

10.6

25.2

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

50.4

25.2

N03AX16

ATC

pregabalin; oral

1.6

25.2

785

5357

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

25.0

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

25.0

L02BG06

ATC

exemestane; oral

+∞

25.0

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

25.0

H47.1

ICD-10 Finland

Papilloedema, unspecified

11.6

24.9

WZC30

NOMESCO Finland

Teaching

2.1

24.7

315

1610

L03AA14

ATC

lipegfilgrastim; parenteral

251.9

24.7

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.3

24.6

244

1116

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

24.6

471

2795

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

7.2

24.3

B01AB10

ATC

tinzaparin; parenteral

2.7

24.0

174

674

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

24.0

WX704

NOMESCO Finland

Intubation

2.3

23.9

221

977

ZXA00

NOMESCO Finland

Right side

1.6

23.9

872

6174

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

241.5

23.7

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

41.7

23.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

23.6

317

1655

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.4

23.4

203

869

183

Kela drug reimbursment

Lamotrigin and topiramate

6.8

23.3

UKC02

NOMESCO Finland

Cystoscopy

1.8

23.3

446

2643

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

14.1

23.0

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

8.6

23.0

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

22.9

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

84.0

22.7

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

231.4

22.6

D33.43

ICD-10 Finland

Spinal cord

231.4

22.6

9560/0-C72.0

ICD-O-3

Schwannoma, NOS, of spinal cord

231.4

22.6

Z51.0

ICD-10 Finland

Radiotherapy session

231.4

22.6

101

Kela drug reimbursment

Anterior pituitary hypofunction

9.9

22.5

N02AA05

ATC

oxycodone; systemic

1.9

22.5

371

2088

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

22.3

293

1516

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

22.2

326

1760

E23.00

ICD-10 Finland

Panhypopituitarism

10.4

22.0

9537/0-C70.9

ICD-O-3

Transitional meningioma of meninges, NOS

+∞

21.9

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

21.9

D33.4

ICD-10 Finland

Benign neoplasm: Spinal cord

+∞

21.9

9531/0-C70.9

ICD-O-3

Meningothelial meningioma of meninges, NOS

+∞

21.9

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.3

21.8

114

357

D33.40

ICD-10 Finland

Benign glioma of the spinal cord (grade I)

221.3

21.6

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

221.3

21.6

N06AX11

ATC

mirtazapine; oral

1.5

21.3

1009

7540

ZZF00

NOMESCO Finland

Graft of adipose tissue

15.6

21.0

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

+∞

20.8

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

20.8

9539/1-C70.9

ICD-O-3

Atypical meningioma of meninges, NOS

+∞

20.8

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

20.8

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

8.6

20.8

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

211.2

20.6

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

110.7

20.6

JN4CD

NOMESCO Finland

Very extensive body CT

4.1

19.9

198

1CD02

NOMESCO Finland

+∞

19.8

2254A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Spinal meninges

+∞

19.8

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

19.6

296

1613

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

201.1

19.6

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

6.3

19.5

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

19.4

220

1071

L28

ICPC

Limited function/disability (L)

1.6

19.3

550

3641

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.7

19.3

139

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.9

18.9

116

407

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

55.3

18.9

D33.7

ICD-10 Finland

Benign neoplasm: Other specified parts of central nervous system

55.3

18.9

R53

ICD-10 Finland

Malaise and fatigue

1.6

18.8

641

4430

N02AX02

ATC

tramadol; systemic, rectal

1.4

18.8

1253

9952

ZX120

NOMESCO Finland

Intravenous

2.1

18.8

220

1086

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

18.8

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

18.8

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

18.8

L01AX03

ATC

temozolomide; systemic

+∞

18.8

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.8

18.7

210

NA2DG

NOMESCO Finland

Thoracal spine very extensive MRI examination with high intensity magnet

17.2

18.7

2312

FHL

Extirpation or destruction

190.9

18.5

N74

ICPC

Malignant neoplasm nervous system

190.9

18.5

2250A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Brain

190.9

18.5

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

18.5

426

2659

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.8

18.1

206

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

5.4

17.9

102

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

17.9

243

1269

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

17.9

227

1157

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

17.8

174

790

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

17.7

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

17.7

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

+∞

17.7

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

17.7

1423

11641

UJF32

NOMESCO Finland

Coloscopy

1.5

17.7

766

5580

ABB10

NOMESCO Finland

Resection of lesion of spinal canal

36.9

17.6

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.4

17.6

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

180.8

17.5

R50.9

ICD-10 Finland

Fever, unspecified

1.8

17.4

342

2035

N03AX12

ATC

gabapentin; oral

1.6

17.2

508

3384

A02BC05

ATC

esomeprazole; systemic

1.4

17.2

1278

10296

R4120

NOMESCO Finland

Occupational therapy

2.1

17.2

208

1041

J01DB01

ATC

cefalexin; oral

1.4

17.1

2517

22741

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

17.0

1172

9320

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

6.8

16.9

WX002

NOMESCO Finland

Sedation and analgesia

1.5

16.8

616

4319

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

16.7

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

16.7

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

16.7

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

16.7

G91.1

ICD-10 Finland

Obstructive hydrocephalus

10.4

16.6

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

8.8

16.6

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

12.7

16.6

D33.0

ICD-10 Finland

Benign neoplasm: Brain, supratentorial

90.5

16.6

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.5

16.5

223

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

170.7

16.5

R4150

NOMESCO Finland

Neuropsychological rehabilitation

6.8

16.5

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.3

16.4

140

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

9.5

16.4

A28

ICPC

Limited function/disability NOS

1.6

16.3

481

3199

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.1

16.2

281

R13

ICD-10 Finland

Dysphagia

2.0

16.1

212

1096

ZX112

NOMESCO Finland

Subcutaneous

5.9

16.0

H93.1

ICD-10 Finland

Tinnitus

2.0

15.9

213

1106

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

15.9

111

423

Q85.01

ICD-10 Finland

Neurofibromatosis, type 2

60.3

15.8

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

33.5

15.7

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

7.3

15.7

H02AB06

ATC

prednisolone; systemic

1.4

15.7

1423

11799

C90.0

ICD-10 Finland

Multiple myeloma

+∞

15.6

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

+∞

15.6

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

15.6

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

15.6

2151

FHL

Resection, big brain

85.5

15.6

22500

ICD-8 Finland

Benign neoplasm of brain and other parts of nervous system, Brain

160.7

15.5

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

160.7

15.5

DFF00

NOMESCO Finland

Pure tone audiometry

1.8

15.5

292

1714

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

3.0

15.4

307

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

15.4

281

1632

G44.2

ICD-10 Finland

Tension-type headache

1.6

15.3

424

2775

N03AX11

ATC

topiramate; oral

3.1

15.2

282

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

15.2

648

4684

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

15.0

526

3646

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

6.1

15.0

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

14.8

234

1292

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

18.4

14.7

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

14.6

HAC25

NOMESCO Finland

Radical mastectomy

+∞

14.6

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

14.6

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

14.6

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

14.6

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

14.6

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

14.6

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

+∞

14.6

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

80.4

14.6

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

80.4

14.6

C82.1

ICD-10 Finland

Follicular lymphoma grade II

150.6

14.5

WX892

NOMESCO Finland

Monitored bed care

1.9

14.3

205

1094

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.2

14.2

229

D31.6

ICD-10 Finland

Benign neoplasm: Orbit, unspecified

22.3

14.2

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

14.0

235

1326

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

2.2

14.0

138

630

XW000

NOMESCO Finland

Bone marrow biopsy

2.6

14.0

381

N01

ICPC

Headache

1.7

14.0

270

1597

G82.2

ICD-10 Finland

Paraplegia, unspecified

8.9

13.9

D43.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Spinal cord

53.5

13.8

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.0

13.8

266

AAK10

NOMESCO Finland

Repair of dura

20.1

13.8

N06AX16

ATC

venlafaxine; oral

1.6

13.7

369

2395

A02BC01

ATC

omeprazole; systemic

1.4

13.7

854

6614

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

3.8

13.7

156

ZXA10

NOMESCO Finland

Bilateral

1.5

13.6

589

4262

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

13.6

993

7903

H05.2

ICD-10 Finland

Exophthalmic conditions

12.1

13.6

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

13.5

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

13.5

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

+∞

13.5

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

13.5

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

13.5

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

13.5

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

+∞

13.5

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

13.5

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

13.5

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

13.5

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

13.5

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

7.2

13.5

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

8.3

13.5

TQW99

NOMESCO Finland

Other minor procedure on skin

2.4

13.4

116

499

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

7.7

13.3

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.9

13.3

275

R4130

NOMESCO Finland

Speech therapy

3.1

13.2

236

JN6AD

NOMESCO Finland

CT of torso and neck

10.5

13.2

Z31.5

ICD-10 Finland

Genetic counselling

2.5

13.2

105

433

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

13.1

201

1101

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

15.1

13.1

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

13.0

127

580

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

13.0

131

605

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

28.5

12.9

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

50.2

12.8

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.3

12.8

192

N18

ICPC

Paralysis/weakness

3.0

12.8

252

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.6

12.8

351

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

12.7

470

3286

M03BX01

ATC

baclofen; systemic

3.3

12.6

189

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.7

12.6

279

1716

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

70.1

12.6

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

12.5

185

1002

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

12.5

2040A

ICD-9 Finland

Lymphoid leukaemia, Acute

+∞

12.5

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

12.5

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

12.5

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

12.5

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

12.5

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

12.5

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

9.3

12.5

2159

FHL

Other measure in this category

130.4

12.4

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

130.4

12.4

WF001

NOMESCO Finland

Preoperative radiotherapy

130.4

12.4

ZXC86

NOMESCO Finland

Use of endoscopic device

6.0

12.4

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

12.3

322

2072

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.2

12.3

129

608

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.9

12.3

131

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

12.2

348

2292

A02BC03

ATC

lansoprazole; oral

1.3

12.2

913

7268

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

3.4

12.2

173

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.8

12.1

286

AA1AA

NOMESCO Finland

Head X-ray examination

5.0

12.1

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

12.4

12.1

R51

ICD-10 Finland

Headache

2.0

12.0

154

790

R11

ICD-10 Finland

Nausea and vomiting

1.7

12.0

231

1364

G40.89

ICD-10 Finland

Other epilepsy

7.5

11.9

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

46.8

11.9

2396A

ICD-9 Finland

Neoplasm of unspecified nature, Brain

46.8

11.9

N05BA01

ATC

diazepam; systemic, rectal

1.5

11.9

421

2916

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

2.6

11.9

320

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

11.7

164

870

D42.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Meninges, unspecified

65.1

11.6

S77

ICPC

Malignant neoplasm of skin

19.0

11.6

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

22.9

11.6

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

11.5

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

11.5

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

+∞

11.5

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

11.5

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

11.5

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

11.5

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

11.5

9532/0-C70.9

ICD-O-3

Fibrous meningioma of meninges, NOS

+∞

11.5

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

11.5

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

+∞

11.5

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

11.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

11.5

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

11.5

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

11.5

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

120.4

11.4

KCD02

NOMESCO Finland

Transurethral resection of bladder

7.9

11.3

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

11.3

195

1111

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.4

11.3

162

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

11.3

211

1235

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

11.3

291

1868

G51.0

ICD-10 Finland

Bell palsy

2.6

11.3

322

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

11.3

174

957

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

11.2

287

1837

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

11.2

1406

12022

D33.39

ICD-10 Finland

Benign tumor of the cranial nerves UNS

25.1

11.1

N29

ICPC

Neurological sympt/complt other

2.8

11.1

260

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

11.1

302

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

11.1

908

7312

A02BA02

ATC

ranitidine; systemic

1.4

11.0

614

4640

D70.82

ICD-10 Finland

Drug-induced neutropenia

7.1

11.0

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

11.0

847

6751

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

11.0

208

1224

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

43.4

10.9

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

10.9

209

1234

N28

ICPC

Limited function/disability (N)

3.1

10.9

195

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

10.8

1864

16572

102

Kela drug reimbursment

Diabetes insipidus

10.6

10.8

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

10.6

10.8

A06AD11

ATC

lactulose; oral

1.5

10.7

410

2885

AWW99

NOMESCO Finland

Other reoperation in surgery of the nervous system

28.1

10.7

D33.37

ICD-10 Finland

Another benign tumor of the cranial nerves

28.1

10.7

S06.0

ICD-10 Finland

Concussion

1.6

10.7

288

1866

G47.3

ICD-10 Finland

Sleep apnoea

1.4

10.7

539

4003

PJW99

NOMESCO Finland

Other operation on lymphatic system

60.2

10.6

D33.46

ICD-10 Finland

Benign neurofibroma in the nerve root of the spinal cord

60.2

10.6

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

60.2

10.6

AAE99

NOMESCO Finland

Other operation by cranial base approach

60.2

10.6

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

8.0

10.6

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

8.0

10.6

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

10.6

128

644

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.3

10.5

425

H46

ICD-10 Finland

Optic neuritis

4.5

10.5

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

10.0

10.5

N06AX26

ATC

vortioxetine; oral

2.0

10.5

140

732

N05BA04

ATC

oxazepam; oral

1.4

10.4

716

5600

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

110.3

10.4

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

110.3

10.4

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

110.3

10.4

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

10.4

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

10.4

153

Kela drug reimbursment

Lenalidomid

+∞

10.4

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

10.4

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

10.4

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

10.4

D43.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system

+∞

10.4

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

10.4

G992, D321

ICD-10 Finland

+∞

10.4

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

10.4

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

10.4

9533/0-C70.0

ICD-O-3

Psammomatous meningioma of cerebral meninges

+∞

10.4

N03AX09

ATC

lamotrigine; oral

2.1

10.4

120

593

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

32.6

10.3

J01MA02

ATC

ciprofloxacin; systemic

1.3

10.3

1083

9016

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.6

10.1

288

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

10.1

212

1284

G04CA02

ATC

tamsulosin; oral

1.5

10.1

408

2902

N05BA09

ATC

clobazam; oral

6.4

10.0

N80

ICPC

Head injury other

3.0

10.0

193

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

9.9

608

4667

N06AX21

ATC

duloxetine; oral

1.5

9.9

311

2095

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

9.9

1024

8495

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

9.9

309

2078

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

6.7

9.9

C08CA01

ATC

amlodipine; oral

1.3

9.9

1092

9137

KAC10

NOMESCO Finland

Total nephrectomy with capsule

16.7

9.9

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.2

9.8

426

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

9.8

441

3202

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

9.8

206

1250

G40

ICD-10 Finland

Epilepsy

4.2

9.8

TQB05

NOMESCO Finland

Puncture of skin of trunk

8.1

9.8

UDC00

NOMESCO Finland

Ear microscopy

1.7

9.8

199

1197

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

9.8

178

1034

G91.0

ICD-10 Finland

Communicating hydrocephalus

5.4

9.8

G93.0

ICD-10 Finland

Cerebral cysts

7.0

9.8

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

9.7

306

2062

ZXC96

NOMESCO Finland

Robot assisted procedure

5.0

9.7

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

9.7

308

2082

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

55.1

9.6

H54.4

ICD-10 Finland

Blindness, monocular

7.8

9.6

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

9.6

147

809

N06AB10

ATC

escitalopram; oral

1.4

9.5

511

3831

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

9.5

476

3526

D33.3

ICD-10 Finland

Benign neoplasm: Cranial nerves

15.0

9.5

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

15.0

9.5

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

5.7

9.5

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.4

9.5

319

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

100.3

9.4

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

30.1

9.4

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.9

9.4

192

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

9.4

T32.0

ICD-10 Finland

Corrosions involving less than 10% of body surface

+∞

9.4

L02BA03

ATC

fulvestrant; parenteral

+∞

9.4

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

9.4

20400

ICD-8 Finland

Lymphatic leukaemia, Acute

+∞

9.4

1501

Kela drug reimbursment

Palbociclib

+∞

9.4

WW300

NOMESCO Finland

Transfer of autologic stem cells

+∞

9.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

9.4

394

Kela drug reimbursment

Palbociclib

+∞

9.4

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

9.4

L04AX04

ATC

lenalidomide; oral

+∞

9.4

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

9.4

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

9.4

H50.2

ICD-10 Finland

Vertical strabismus

4.3

9.4

S82

ICPC

Naevus/mole

1.5

9.4

322

2214

K07.60

ICD-10 Finland

Snapping jaw

1.9

9.3

133

712

HA1SA

NOMESCO Finland

Expansion mammography

21.7

9.3

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

21.7

9.3

AAK40

NOMESCO Finland

Closure of cerebrospinal fluid fistula

21.7

9.3

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

9.3

324

2234

9560/0-C72.4

ICD-O-3

Schwannoma, NOS, of acoustic nerve

8.7

9.3

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

4.9

9.3

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

3.3

9.2

139

N88

ICPC

Epilepsy

5.0

9.2

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

9.2

596

4611

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.3

9.1

344

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

9.1

1324

11436

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.4

9.1

316

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.9

9.1

191

SPAT1216

SPAT

Assessment of functional ability

1.4

9.1

480

3590

AAF00

NOMESCO Finland

Ventriculostomy

4.6

9.1

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

15.6

9.0

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

36.8

9.0

N06AB04

ATC

citalopram; systemic

1.3

9.0

639

5010

ZXH01

NOMESCO Finland

Procedure performed within operation theatre

7.0

9.0

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.7

9.0

222

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.4

8.9

303

Q85.09

ICD-10 Finland

Unspecified neurofibromatosis

18.6

8.9

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

7.4

8.9

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

8.9

139

769

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

8.9

455

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

8.8

911

7529

CE2W4

NOMESCO Finland

Eye movement mapping

8.6

8.8

P20

ICPC

Memory disturbance

1.4

8.8

389

2816

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

8.7

361

2580

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

8.7

118

624

C43

ICD-10 Finland

Malignant melanoma of skin

50.1

8.7

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

50.1

8.7

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

50.1

8.7

XX1AD

NOMESCO Finland

Other CT-examination

50.1

8.7

R06AE07

ATC

cetirizine; oral

1.3

8.6

1248

10752

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

7.6

8.6

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.8

8.6

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

8.6

361

2584

J02AC01

ATC

fluconazole; systemic

1.3

8.6

1213

10423

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

8.5

1001

8407

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.7

8.5

J01MA12

ATC

levofloxacin; systemic

1.4

8.5

447

3336

KAC00

NOMESCO Finland

Nephrectomy

27.6

8.5

ZZC00

NOMESCO Finland

Graft of fascia

20.1

8.5

TQW20

NOMESCO Finland

Tatoe

20.1

8.5

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

8.4

319

2235

K91

ICPC

Cerebrovascular disease

2.9

8.4

177

WW500

NOMESCO Finland

Blood transfusion

2.5

8.4

256

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

90.3

8.4

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

90.3

8.4

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

90.3

8.4

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

90.3

8.4

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

8.3

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

8.3

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

8.3

L01XE33

ATC

[U] palbociclib; oral

+∞

8.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

8.3

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

+∞

8.3

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

8.3

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

8.3

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

+∞

8.3

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

8.3

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

8.3

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

+∞

8.3

9531/0-C70.1

ICD-O-3

Meningothelial meningioma of spinal meninges

+∞

8.3

9537/0-C70.1

ICD-O-3

Transitional meningioma of spinal meninges

+∞

8.3

L01CA04

ATC

vinorelbine; systemic

+∞

8.3

D33.15

ICD-10 Finland

Another benign tumor of the cerebellum

+∞

8.3

C71.12

ICD-10 Finland

Malignant tumor of frontal lobe grade III glioma

+∞

8.3

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

+∞

8.3

192

Kela drug reimbursment

Fulvestrant

+∞

8.3

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.6

8.3

102

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

8.3

443

ZZR10

NOMESCO Finland

Flap of skin and muscle

10.8

8.3

D36.1

ICD-10 Finland

Benign neoplasm: Peripheral nerves and autonomic nervous system

9.4

8.3

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.8

8.3

174

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.4

8.2

296

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

6.5

8.2

SPAT1053

SPAT

Memory test

1.4

8.2

477

3626

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

8.1

351

2524

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

7.5

8.1

S04

ICPC

Lump/swelling localized

1.6

8.1

233

1537

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

8.1

763

6222

Q85.0

ICD-10 Finland

Neurofibromatosis (nonmalignant)

33.4

8.1

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

33.4

8.1

NA7FT

NOMESCO Finland

Labeling lesion in spinal area with X-ray guidance

17.2

8.1

AA1CF

NOMESCO Finland

Extensive MRI examination of brain with median intensity magnet

17.2

8.1

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.9

8.1

113

605

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.0

8.1

456

H01CB02

ATC

octreotide; parenteral

22.1

8.0

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.5

8.0

238

PJA10

NOMESCO Finland

Exploration of lymph nodes

5.5

8.0

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

8.0

2737

25905

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

7.9

151

894

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

7.9

104

544

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.5

7.9

222

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

13.0

7.9

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

2.2

7.9

351

R51.81

ICD-10 Finland

Facial pain NOS

2.3

7.8

290

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.3

7.8

290

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

3.2

7.8

124

Z71.8

ICD-10 Finland

Other specified counselling

1.3

7.8

612

4863

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

7.8

163

990

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

7.8

505

3899

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

9.4

7.8

SPAT1301

SPAT

No procedures

1.3

7.7

933

7844

R4190

NOMESCO Finland

Nutritional therapy

2.5

7.7

237

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

7.7

243

1638

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

45.1

7.7

AAK99

NOMESCO Finland

Other operation on skull or dura

45.1

7.7

23810

ICD-8 Finland

Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain

45.1

7.7

ZZA50

NOMESCO Finland

Full thickness skin graft

15.0

7.7

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

7.7

419

3146

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

7.7

116

638

H03AA01

ATC

levothyroxine sodium; systemic

1.3

7.7

768

6306

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

2.7

7.7

181

E23.2

ICD-10 Finland

Diabetes insipidus

7.4

7.7

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.0

7.7

459

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

18.4

7.6

J05AB11

ATC

valaciclovir; oral

1.4

7.6

341

2475

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

4.2

7.6

9101

FHL

Bone biopsy

11.9

7.6

Q85.1

ICD-10 Finland

Tuberous sclerosis

25.0

7.6

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

7.6

334

2417

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.6

7.5

191

BAA60

NOMESCO Finland

Total thyroidectomy

2.5

7.5

234

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

10.0

7.5

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

7.5

108

584

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

7.5

1113

9582

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

7.1

7.5

N07CA01

ATC

betahistine; oral

1.5

7.5

227

1521

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

7.4

524

4100

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

80.2

7.4

D42.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Spinal meninges

80.2

7.4

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

80.2

7.4

D33.11

ICD-10 Finland

Brain stem

80.2

7.4

XX1XN

NOMESCO Finland

Other isotope examination

80.2

7.4

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

80.2

7.4

G35

ICD-10 Finland

Multiple sclerosis

2.7

7.4

180

N04BC06

ATC

cabergoline; oral (dopamine agonists)

5.0

7.4

N17

ICPC

Vertigo/dizziness

1.4

7.4

341

2487

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

7.4

132

769

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

7.4

403

R33

ICD-10 Finland

Retention of urine

1.6

7.3

163

1010

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

7.3

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

7.3

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

7.3

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

+∞

7.3

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

7.3

C71.9

ICD-10 Finland

Malignant neoplasm: Brain, unspecified

+∞

7.3

8000/0-C70.9

ICD-O-3

Neoplasm, benign of meninges, NOS

+∞

7.3

8010/3-C50.9

ICD-O-3

Carcinoma, NOS, of breast, NOS

+∞

7.3

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

+∞

7.3

197

Kela drug reimbursment

Sunitinib

+∞

7.3

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

7.3

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

7.3

C71.60

ICD-10 Finland

Malignant tumor of cerebellum without histology

+∞

7.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

7.3

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

+∞

7.3

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

7.3

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

7.3

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

7.3

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

+∞

7.3

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

7.3

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

7.3

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

7.3

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

+∞

7.3

L01XE04

ATC

[U] sunitinib; oral

+∞

7.3

C71.09

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology

+∞

7.3

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

7.3

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

7.3

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

7.3

D33.01

ICD-10 Finland

Medial ganglion glioma of the cerebrum

+∞

7.3

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

+∞

7.3

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

7.3

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

7.3

176

1117

N99

ICPC

Neurological disease other

2.8

7.2

154

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

15.8

7.2

R31

ICD-10 Finland

Unspecified haematuria

1.6

7.2

203

1334

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

7.2

149

906

S09.9

ICD-10 Finland

Unspecified injury of head

3.0

7.2

127

M54.5

ICD-10 Finland

Low back pain

1.2

7.1

921

7790

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

7.1

460

3547

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

30.1

7.1

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

7.1

386

2895

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

7.1

262

1827

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

20.0

7.1

WZA90

NOMESCO Finland

Other doctors statement

1.3

7.1

593

4747

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

7.1

706

5784

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.7

7.1

173

S29

ICPC

Skin symptom/complaint other

1.3

7.1

449

3452

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

7.1

188

1221

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.5

7.1

198

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.1

7.1

117

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.8

7.1

120

689

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

7.0

152

939

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

7.0

289

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

6.9

287

2050

SPAT1043

SPAT

Audiometry

1.4

6.9

313

2276

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

3.2

6.9

108

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

4.2

6.9

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.8

6.9

120

694

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

2.1

6.9

338

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

2.5

6.9

203

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

2.0

6.8

400

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.5

6.8

202

1345

P01AB01

ATC

metronidazole; oral, rectal

1.2

6.8

1135

9867

21899

ICD-8 Finland

Uterine fibroma

1.6

6.8

160

1009

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

9.3

6.8

G00.9

ICD-10 Finland

Bacterial meningitis, unspecified

9.3

6.8

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

2.8

6.8

143

ZXB10

NOMESCO Finland

Medial

6.1

6.8

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

40.1

6.8

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

40.1

6.8

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.4

6.7

217

SPAT1229

SPAT

Assessment of need for aid

1.5

6.7

237

1639

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

7.2

6.7

AA6AD

NOMESCO Finland

Cranial bones CT examination

22.5

6.7

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

4.9

6.6

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

6.6

414

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.1

6.6

106

KMAK

NOMESCO Finland

1.2

6.6

1393

12389

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

3.4

6.6

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

3.4

6.6

N03AX15

ATC

zonisamide; oral

7.8

6.6

UDM02

NOMESCO Finland

Sinoscopy

2.2

6.6

272

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

6.6

1306

11544

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.5

6.6

188

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

4.6

6.6

K90

ICPC

Stroke/cerebrovascular accident

1.9

6.6

432

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

8.7

6.5

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

6.5

424

3273

U04

ICPC

Incontinence urine

1.7

6.5

136

831

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

2.2

6.5

300

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

6.8

6.5

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.7

6.5

148

JDB10

NOMESCO Finland

Percutaneous gastrostomy

4.1

6.5

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

6.5

153

964

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

6.5

116

677

R55

ICD-10 Finland

Syncope and collapse

1.4

6.4

301

2201

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

70.0

6.4

WF090

NOMESCO Finland

Profylactic radiotherapy

70.0

6.4

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

70.0

6.4

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

70.0

6.4

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

70.0

6.4

D33

ICD-10 Finland

Benign neoplasm of brain and other parts of central nervous system

70.0

6.4

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

70.0

6.4

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.2

6.4

294

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.0

6.4

418

R35

ICD-10 Finland

Polyuria

1.6

6.4

154

976

H01AC01

ATC

somatropin; parenteral

14.3

6.4

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

14.3

6.4

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

6.4

124

741

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

2.9

6.4

121

J01CA08

ATC

pivmecillinam; oral

1.2

6.3

1338

11890

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

4.4

6.3

HAE99

NOMESCO Finland

Other reconstruction of breast

8.1

6.3

G04BD12

ATC

mirabegron; oral

1.4

6.3

294

2150

AAF15

NOMESCO Finland

Ventriculoatrial shunt

5.9

6.3

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

11.0

6.3

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

9.3

6.3

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.5

6.3

170

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

+∞

6.2

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

6.2

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

6.2

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

6.2

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

6.2

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

6.2

L02BX02

ATC

degarelix; parenteral

+∞

6.2

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

6.2

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

6.2

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

+∞

6.2

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

+∞

6.2

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

6.2

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

6.2

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

6.2

2192

FHL

Cranioplasty

+∞

6.2

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

6.2

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

6.2

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

6.2

Z85.6

ICD-10 Finland

Personal history of leukaemia

+∞

6.2

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

6.2

8211/3-C50.9

ICD-O-3

Tubular adenocarcinoma of breast, NOS

+∞

6.2

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

6.2

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

6.2

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

6.2

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

+∞

6.2

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

+∞

6.2

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

+∞

6.2

22540

ICD-8 Finland

Benign neoplasm of brain and other parts of nervous system, Spinal meninges

+∞

6.2

8140/3-C80.9

ICD-O-3

Adenocarcinoma, NOS, of unknown primary site

+∞

6.2

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

+∞

6.2

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

6.2

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

6.2

D33.06

ICD-10 Finland

Plexus papilloma of the ventricle of the brain

+∞

6.2

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

6.2

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

6.2

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

6.2

C71.89

ICD-10 Finland

Overall malignant tumor of the brain other or unspecified histology

+∞

6.2

C71.19

ICD-10 Finland

Malignant tumor of frontal lobe other or unspecified histology

+∞

6.2

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

6.2

329

Kela drug reimbursment

Lenalidomide

+∞

6.2

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

+∞

6.2

C32.1

ICD-10 Finland

Malignant neoplasm: Supraglottis

+∞

6.2

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

+∞

6.2

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.1

6.2

100

C09CA01

ATC

losartan; oral

1.3

6.2

704

5852

ZZR50

NOMESCO Finland

Mucoperiosteal flap

26.7

6.2

H01CB03

ATC

lanreotide; parenteral

26.7

6.2

D33.10

ICD-10 Finland

Benign pilosytic astrocytoma of brain stem

26.7

6.2

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

26.7

6.2

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

26.7

6.2

9560/0-C72.9

ICD-O-3

Schwannoma, NOS, of nervous system, NOS

26.7

6.2

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

6.2

279

2025

G50.1

ICD-10 Finland

Atypical facial pain

2.3

6.2

251

H57.1

ICD-10 Finland

Ocular pain

1.9

6.2

464

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.1

6.2

295

J01CA04

ATC

amoxicillin; systemic

1.2

6.2

2385

22422

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

6.1

213

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

6.1

484

E21.0

ICD-10 Finland

Primary hyperparathyroidism

2.3

6.1

215

G04CA01

ATC

alfuzosin; oral

1.5

6.1

180

1199

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

6.1

267

N63

ICD-10 Finland

Unspecified lump in breast

1.6

6.1

133

822

CBK11

NOMESCO Finland

Operation for lagophtalmus with implant

12.5

6.1

J01EA01

ATC

trimethoprim; systemic

1.2

6.1

784

6617

N03AE01

ATC

clonazepam; systemic

1.6

6.1

163

1061

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.9

6.1

123

R93.0

ICD-10 Finland

Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified

8.6

6.0

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

2.5

6.0

179

M05BX04

ATC

denosumab; parenteral

1.7

6.0

129

792

D22.4

ICD-10 Finland

Melanocytic naevi of scalp and neck

2.8

6.0

124

C07AB07

ATC

bisoprolol; oral

1.2

6.0

1422

12754

JAH01

NOMESCO Finland

Laparoscopy

1.8

6.0

512

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726)

641

910

8.25

307.65

1.4

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

403

145

30.93

307.65

1.6

1.9

—

(3003396) Base excess in Arterial blood by calculation

970

3126

3.81

254.92

5.6

6.8

1.0

1.5

mmol/l

3.00

702

2437

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

968

3151

3.77

250.21

5.7

6.8

5.0

5.1

kpa

4.87

935

2997

(3027801) Oxygen [Partial pressure] in Arterial blood

967

3149

3.77

249.76

5.7

6.8

16.3

11.6

kpa

69.92

933

2986

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

582

1353

4.89

235.71

5.1

8.6

24.1

24.6

mmol/l

3.33

567

1239

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2482

15868

2.59

168.98

7.6

5.4

1.2

mmol/l

9.85

2161

13244

(40768804) Tissue Pathology biopsy report

1899

10732

2.52

168.55

2.4

1.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2297

14239

2.53

165.81

6.6

5.0

1.2

mmol/l

11.64

2115

12510

(3044640) Blood type and Crossmatch panel - Blood

1608

8555

2.51

160.61

2.4

2.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2684

18146

2.59

156.75

5.6

4.1

6.6

6.7

mmol/l

2.33

2580

16823

(3033658) Prothrombin time (PT) actual/Normal

1359

7105

2.41

136.19

3.8

3.4

93.6

90.2

5.41

1317

6902

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2060

13078

2.24

127.77

4.0

3.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

959

4433

2.55

123.98

2.1

1.9

28.9

29.7

3.23

926

4281

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1248

6563

2.34

120.65

2.3

2.0

—

(3032080) INR in Blood by Coagulation assay

1924

12258

2.14

113.63

8.0

9.5

1.2

1.3

inr

3.33

496

3458

(3044290) Cell count panel - Cerebral spinal fluid

263

572

4.86

113.22

1.6

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

176

264

6.94

112.25

1.9

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

624

2571

2.70

100.11

7.2

7.6

121.4

121.1

g/l

0.13

607

2467

(3016018) Differential panel - Cerebral spinal fluid

172

296

6.04

95.83

1.8

1.4

—

(3016502) Oxygen saturation in Arterial blood

654

2817

2.59

95.61

7.0

7.2

96.9

95.2

9.93

640

2698

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

455

1654

2.99

91.95

7.0

8.3

0.7

1.25

455

1642

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

454

1668

2.95

89.93

7.0

8.3

1.3

1.4

3.03

454

1656

(3014007) Fractional oxyhemoglobin in Arterial blood

452

1663

2.95

89.28

7.0

8.4

95.2

93.5

8.80

452

1656

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

251

638

4.14

88.33

1.6

1.3

69.6

26.0

e6/l

0.93

193

495

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

251

640

4.13

87.95

1.7

1.4

1545.8

1317.9

e6/l

0.14

197

524

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

103

109

9.68

87.68

2.3

2.2

51.7

54.2

umol/l

0.26

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2118

14835

1.95

87.37

6.1

3.7

10.6

11.2

umol/l

1.31

1994

13776

(3036481) Cortisol [Moles/volume] in Serum or Plasma

624

2742

2.52

86.90

2.8

1.8

368.9

369.2

nmol/l

0.01

579

2458

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1619

10375

1.97

86.72

2.3

2.1

157.5

205.7

u/l

1.61

1533

9641

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

114

144

8.13

84.47

2.0

1.6

—

(3002256) Pathology report gross observation

560

2494

2.46

75.04

1.3

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

253

733

3.62

73.73

1.4

1.2

706.4

531.9

mg/l

2.49

239

692

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

232

637

3.81

73.15

1.3

1.2

3.6

3.8

mmol/l

1.66

207

596

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

418

1719

2.61

65.87

3.6

1.4

15.0

11.2

ug/l

0.14

333

1275

(3013650) Neutrophils [#/volume] in Blood by Automated count

2211

16646

1.77

63.29

9.3

6.4

4.1

4.2

e9/l

0.69

1945

14260

(3023410) Appearance of Cerebral spinal fluid

134

271

5.09

62.55

1.9

1.5

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

669

3456

2.13

62.13

6.3

6.0

104.8

104.1

mmol/l

3.53

657

3375

(3024561) Albumin [Mass/volume] in Serum or Plasma

1810

12957

1.75

60.98

4.9

3.7

35.1

35.7

g/l

5.39

1673

11791

(3023368) Bacteria identified in Blood by Culture

1175

7456

1.83

59.46

4.7

3.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2894

23834

1.87

58.84

8.3

5.4

78.3

76.2

u/l

1.78

2730

21933

(3012095) Magnesium [Moles/volume] in Serum or Plasma

780

4352

1.99

58.39

2.7

2.4

0.8

mmol/l

1.17

716

3959

(3019060) Gas panel - Arterial blood

418

1905

2.34

52.23

5.8

4.9

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

203

644

3.27

51.14

2.7

1.7

408.2

297.9

mu/l

2.77

194

572

(3031040) Bacteria [#/volume] in Urine by Automated count

2604

21201

1.71

50.09

5.7

4.7

694.3

2996.2

e6/l

2.90

277

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

105

209

5.14

49.91

1.5

1.2

2.5

2.1

mmol/l

1.38

198

(3018418) pH of Serum or Plasma

1354

9359

1.69

48.61

4.5

3.2

7.4

0.67

230

1595

(3008152) Bicarbonate [Moles/volume] in Arterial blood

396

1831

2.30

47.68

8.8

6.9

24.9

24.8

mmol/l

0.29

381

1685

(40768793) Breast Pathology biopsy report

114

255

4.58

47.18

1.4

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

13.48

46.80

6.8

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

462

2327

2.12

44.87

5.8

6.7

8.1

10.3

mmol/l

8.62

434

2196

(3015377) Calcium [Moles/volume] in Serum or Plasma

1444

10361

1.63

43.60

3.5

2.1

2.4

mmol/l

0.56

1227

8605

(42870588) Differential panel, method unspecified - Blood

1407

10040

1.63

43.39

5.9

5.5

—

(3002582) Erythrocytes [#/volume] in Urine

1283

8959

1.65

43.06

3.5

3.0

47.9

72.4

e6/l

1.05

1007

6714

(3026782) Osmolality of Urine

900

5751

1.74

42.00

3.1

2.6

524.6

526.6

mosm/kgh2o

0.10

785

4768

(3001604) Monocytes [#/volume] in Blood

1942

15096

1.58

41.06

5.9

5.4

0.6

e9/l

0.00

1668

12919

(3022096) Basophils/100 leukocytes in Blood

1779

13562

1.58

40.86

6.2

5.7

0.7

1.28

1650

12432

(3006315) Basophils [#/volume] in Blood

1948

15178

1.58

40.59

5.9

5.5

0.0

e9/l

0.73

1680

12994

(3030467) Casts [#/volume] in Urine by Automated count

1198

8321

1.64

40.53

3.4

2.9

0.4

e6/l

0.17

931

6149

(3019069) Monocytes/100 leukocytes in Blood

1829

14055

1.58

40.42

6.5

5.9

8.5

8.6

0.13

1703

12942

(3043409) Potassium [Moles/volume] in Arterial blood

228

883

2.68

40.09

5.1

4.1

3.8

mmol/l

2.08

222

837

(3006504) Eosinophils/100 leukocytes in Blood

1818

13979

1.57

39.87

6.2

5.6

2.7

2.9

5.88

1685

12802

(3002030) Lymphocytes/100 leukocytes in Blood

1855

14372

1.56

39.05

6.4

5.8

27.5

28.1

1.69

1719

13160

(3019198) Lymphocytes [#/volume] in Blood

1973

15506

1.56

38.93

6.0

5.5

1.9

e9/l

0.45

1724

13517

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

7.08

38.55

2.6

2.2

0.7

1.1

ug/l

1.05

(3013115) Eosinophils [#/volume] in Blood

1993

15727

1.56

38.40

6.2

5.6

0.2

e9/l

6.48

1736

13684

(3018095) Leukocytes [#/volume] in Urine

1461

10756

1.58

38.25

4.0

3.5

70.3

122.0

e6/l

3.24

1075

7338

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

768

4807

1.75

38.11

1.9

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3466

31483

2.03

37.37

19.3

12.7

21.5

22.0

mg/l

0.46

3033

24337

(3003458) Phosphate [Moles/volume] in Serum or Plasma

625

3716

1.81

36.85

5.2

4.8

1.0

mmol/l

0.98

563

3388

(3026008) Bacteria identified in Urine by Culture

1450

10736

1.56

36.58

3.7

3.3

—

(3018010) Neutrophils/100 leukocytes in Blood

1825

14259

1.53

35.83

6.1

5.6

57.8

57.2

1.35

1698

13114

(3037467) Urinalysis macro (dipstick) panel - Urine

2620

22155

1.57

35.78

5.4

4.5

—

(36304419) Bacteria [Presence] in Urine

1146

8081

1.60

35.47

3.3

2.9

—

(3018405) Lactate [Moles/volume] in Arterial blood

242

1024

2.45

35.39

4.9

3.9

1.2

1.4

mmol/l

2.62

242

1000

(3000991) Gas panel - Venous blood

423

2244

1.99

35.29

7.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

297

1383

2.24

34.86

8.7

9.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

22.87

34.11

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

440

2396

1.94

33.97

6.3

6.1

1.4

mmol/l

0.43

427

2316

(40758558) Short blood count panel - Blood

1015

7016

1.61

33.86

6.8

4.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2805

24323

1.57

32.15

4.6

4.3

12.9

12.6

mm/h

0.36

2608

22374

(3020891) Body temperature

263

1211

2.26

31.67

5.3

4.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

70.48

30.89

1.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1617

12649

1.48

29.56

4.1

3.7

39.4

80.3

ng/l

1.03

1171

8696

(3019550) Sodium [Moles/volume] in Serum or Plasma

3566

33151

2.06

29.46

23.0

15.1

139.6

139.8

mmol/l

2.62

3519

32216

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

472

2747

1.82

29.43

4.0

2.9

241.2

238.6

u/l

0.10

440

2542

(3023103) Potassium [Moles/volume] in Serum or Plasma

3571

33246

2.05

28.87

22.9

15.2

4.0

mmol/l

2.97

3519

32256

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

905

6321

1.56

28.04

4.0

3.8

154.2

354.7

ng/l

3.06

690

4995

(3000850) Epithelial cells [#/volume] in Urine

904

6316

1.56

27.96

2.8

2.5

6.2

e6/l

0.05

812

5435

(3042936) Bacteria identified in Isolate by Culture

608

3869

1.68

27.53

2.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

123

419

3.00

27.48

1.6

1.3

11.8

12.2

u/l

0.08

332

(3007853) Bacteria identified in Skin by Aerobe culture

552

3426

1.71

27.43

1.8

—

(40768795) Lymph node Pathology biopsy report

6.68

27.19

1.2

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

696

4611

1.62

26.84

3.0

2.7

3.9

3.5

e6/l

0.27

388

2399

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

122

4.81

25.94

3.1

2.7

28.9

28.6

umol/l

0.08

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2899

25780

1.51

25.33

4.9

4.2

14.9

pmol/l

0.03

2646

23330

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2290

19484

1.43

25.06

3.5

2.9

47.3

44.0

u/l

1.17

2114

17776

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

8.48

24.88

1.2

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

216

1026

2.17

24.05

2.0

2.3

478.8

767.1

ug/l

0.51

196

952

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

119

4.67

23.80

5.8

1.1

9.9

102.0

u/ml

1.45

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

745

5144

1.56

23.79

2.8

2.6

1.1

1.4

e6/l

1.30

437

2911

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

127

477

2.72

23.73

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1226

9408

1.45

23.22

3.2

2.6

31.2

33.9

u/l

0.60

1144

8858

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3289

30229

1.61

23.21

5.9

5.1

3.0

2.0

mu/l

0.64

3021

27532

(3017446) Testosterone [Moles/volume] in Serum or Plasma

205

968

2.18

23.17

2.6

2.2

10.6

13.7

nmol/l

5.69

172

844

(3009466) Valproate [Moles/volume] in Serum or Plasma

116

427

2.77

22.54

3.7

5.0

348.9

366.5

umol/l

0.82

109

364

(3044889) 12 lead EKG panel

2578

22644

1.42

22.03

4.3

3.9

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

241

1235

2.02

21.94

6.1

5.1

1.5

1.6

1.64

224

1161

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

495

3156

1.65

21.92

2.5

2.2

7.6

7.3

umol/l

0.10

412

2672

(3019309) Folate [Moles/volume] in Red Blood Cells

912

6685

1.48

21.66

1.8

1103.5

1185.5

nmol/l

1.91

669

4959

(3035637) Corticotropin [Mass/volume] in Plasma

275

3.18

21.46

1.8

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1263

9866

1.42

21.24

2.6

2.3

60.8

57.8

u/l

0.32

1143

8940

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

425

2626

1.70

21.18

2.4

2.2

30.1

37.2

u/l

2.15

366

2218

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

822

5928

1.49

21.10

3.2

2.2

2.5

mmol/l

0.39

698

5090

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1734

14334

1.38

20.71

2.1

2.0

97.4

97.3

pmol/l

0.01

850

6863

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

339

1988

1.77

20.34

3.0

2.9

4.3

4.5

pmol/l

2.99

304

1732

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

514

3368

1.61

20.30

1.8

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

311

1786

1.81

20.02

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

297

1682

1.83

20.01

1.4

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

511

3357

1.60

19.94

1.8

1.7

—

(40768800) Prostate Pathology biopsy report

100

4.64

19.83

1.1

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

144

627

2.35

19.78

3.0

1.8

2776.7

81.2

u/ml

0.84

117

498

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1708

14157

1.37

19.73

2.4

2.3

78.0

79.7

nmol/l

1.69

1498

12456

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

368

2241

1.71

19.29

2.1

0.2

g/l

1.24

331

2026

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

156

715

2.23

19.00

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3562

33712

1.78

18.96

22.2

14.6

74.7

75.0

umol/l

0.17

3562

33702

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3224

29802

1.51

18.88

17.3

11.6

78.6

77.1

ml/min/173m2

4.20

2859

23883

(3007930) Methemoglobin/Hemoglobin.total in Blood

230

1226

1.93

18.69

6.3

5.2

1.0

0.9

2.04

214

1155

(3023323) Follitropin [Units/volume] in Serum or Plasma

207

1064

2.00

18.69

1.6

1.3

31.8

33.8

iu/l

0.38

184

927

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

347

2101

1.72

18.56

1.7

1.6

—

(3008295) Osmolality of Serum or Plasma

302

2.89

18.30

1.9

1.4

283.7

274.9

mosm/kgh2o

2.64

226

(3021589) Normoblasts [#/volume] in Blood

1613

13375

1.36

18.02

10.6

8.4

0.0

e9/l

0.11

1311

10892

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

324

2.79

17.73

5.7

6.8

10.5

12.2

mg/l

2.64

297

(3003694) ABO and Rh group [Type] in Blood

932

7087

1.42

17.63

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

152

3.66

17.28

1.1

—

(3039000) Anion gap in Blood

137

622

2.25

17.10

8.2

7.6

10.7

11.2

mmol/l

1.07

121

557

(3018572) Chloride [Moles/volume] in Blood

137

622

2.25

17.10

8.2

7.6

107.3

104.7

mmol/l

7.65

121

557

(3005719) IgG [Mass/volume] in Serum or Plasma

331

2025

1.69

17.02

3.0

2.3

9.7

10.7

g/l

4.58

297

1843

(40761511) CBC panel - Blood by Automated count

3468

32723

1.62

16.97

18.7

12.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

6.98

16.53

2.0

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

206

1113

1.90

16.09

1.8

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

239

1359

1.81

15.87

2.9

1.5

43.0

29.0

u/ml

0.50

229

1288

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

254

2.91

15.84

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

217

1199

1.86

15.81

2.0

1.8

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

348

2200

1.64

15.75

2.3

2.4

17.5

25.8

au/ml

0.71

108

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

164

827

2.03

15.65

3.2

0.3

0.4

u/ml

0.17

485

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1574

13227

1.32

15.21

3.0

2.8

126.9

111.9

ug/l

1.47

1424

12081

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

148

3.48

14.94

1.1

1.0

1.1

u/l

0.23

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

189

3.15

14.78

1.2

1.1

55.0

36.0

mg/l

1.19

158

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1009

7968

1.36

14.76

2.4

2.3

3.0

2.9

mg/l

0.24

850

6755

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

318

2000

1.64

14.68

1.2

1.3

45.4

48.5

au/ml

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

299

2.68

14.67

1.1

—

2.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

190

3.14

14.66

1.2

1.0

9.5

10.2

nmol/l

0.04

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

446

3040

1.53

14.59

3.8

3.2

—

(3047181) Lactate [Moles/volume] in Blood

172

906

1.94

14.51

7.5

6.4

1.3

mmol/l

0.91

157

793

(3013512) EKG study

1203

9781

1.33

14.45

4.5

4.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

5.98

14.31

1.6

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

181

3.12

13.85

1.1

335.2

245.9

mg/l

1.24

160

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

287

2.65

13.65

1.1

—

47.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

138

3.44

13.55

1.4

1.2

36.5

54.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

374

2492

1.55

13.53

2.3

1.5

65.4

66.8

g/l

3.63

332

2199

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

153

3.30

13.52

1.0

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

395

2665

1.54

13.51

3.9

3.4

89.1

87.8

ng/l

0.12

338

2229

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

179

3.10

13.45

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

239

2.75

12.80

2.7

2.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

231

2.76

12.48

4.5

3.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

872

6887

1.34

12.42

1.9

1.7

1.5

1.1

mg/l

0.79

672

5256

(3004809) Band form neutrophils/100 leukocytes in Blood

327

2.45

12.27

4.3

3.0

1.8

1.2

0.50

242

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

131

668

2.00

12.19

2.8

2.4

3.4

3.5

g/l

0.40

125

623

(3019225) pH of Specimen

463

3297

1.46

12.13

4.9

3.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

255

1598

1.64

11.94

1.9

1.4

1.5

1.2

g/l

0.52

225

1449

(3009261) Glucose [Presence] in Urine by Test strip

1833

16054

1.27

11.81

4.5

3.9

0.0

estimate

1.32

351

2667

(3021601) Nitrite [Presence] in Urine by Test strip

1815

15885

1.27

11.73

6.0

5.2

0.0

estimate

0.80

361

2684

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1196

9951

1.29

11.57

3.0

1491.6

1347.1

ng/l

0.54

1025

8494

(3035350) Ketones [Presence] in Urine by Test strip

1806

15826

1.27

11.45

4.4

3.9

0.0

estimate

0.00

353

2675

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3523

33771

1.52

11.43

12.6

9.2

24.9

24.3

u/l

0.86

3415

32251

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

581

4355

1.39

11.41

7.8

6.7

—

(3017181) Myelocytes/100 leukocytes in Blood

350

2387

1.51

11.35

4.5

3.7

1.0

0.7

0.97

122

474

(3003181) Sodium [Moles/volume] in Urine

118

595

2.01

11.35

1.2

1.3

74.3

62.7

mmol/l

1.88

474

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

245

2.60

11.17

1.8

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

338

2301

1.51

11.06

4.5

3.8

0.2

0.1

0.80

115

437

(3036489) Thrombin time

175

1012

1.76

11.04

2.2

1.8

21.1

0.04

155

873

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

225

2.65

10.89

2.1

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

103

502

2.08

10.88

2.2

2.8

29.0

34.7

umol/l

1.57

436

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

527

3926

1.40

10.70

2.8

2.5

21.3

22.3

0.85

461

3255

(3021960) Folate [Moles/volume] in Serum or Plasma

979

8004

1.30

10.67

1.6

1.5

20.3

21.3

nmol/l

1.21

832

6673

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

394

2.21

10.64

1.9

1.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

562

4260

1.37

10.25

2.7

2.4

2.3

2.4

g/l

1.17

513

3887

(3011985) Renin [Units/volume] in Plasma

444

2.10

10.00

1.7

1.4

48.0

49.4

mu/l

0.02

394

(3002032) Base excess in Venous blood by calculation

387

2764

1.44

9.94

3.9

3.4

1.7

2.1

mmol/l

1.21

325

2272

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

243

2.49

9.83

1.4

1.3

0.3

nmol/l

0.07

192

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

5.15

9.83

1.4

1.2

49.0

47.3

0.05

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

4.91

9.78

2.5

2.3

44.8

umol/l

0.00

(3017354) Segmented neutrophils/100 leukocytes in Blood

220

2.57

9.77

3.4

2.8

63.0

59.6

0.54

143

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

127

695

1.86

9.65

2.6

2.2

182.6

187.8

0.29

121

652

(4027681)

143

2.96

9.60

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

223

2.53

9.52

1.9

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

351

2481

1.46

9.52

1.6

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

272

1827

1.53

9.48

3.6

3.4

5.2

kpa

0.17

242

1678

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

174

1050

1.69

9.47

2.3

1.8

2.6

1.7

ug/l

0.50

137

906

(3012544) pH of Venous blood

397

2880

1.42

9.35

3.8

3.4

—

7.4

—

(3025159) Blasts/100 leukocytes in Blood

316

2197

1.48

9.33

4.5

3.8

0.0

0.3

0.52

382

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.75

9.31

1.0

1.1

—

(3009343) pH of Capillary blood

268

1804

1.52

9.25

3.6

3.4

7.4

1.96

229

(3021447) Carbon dioxide [Partial pressure] in Venous blood

384

2775

1.43

9.24

3.9

3.4

5.8

5.9

kpa

1.14

377

2694

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

107

565

1.92

9.09

1.8

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

152

896

1.73

9.02

3.1

3.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1975

17775

1.23

8.90

2.8

2.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

5.16

8.87

1.1

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

201

1281

1.60

8.84

1.7

2.0

36.5

39.7

u/l

1.68

171

1110

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

289

2.27

8.71

2.2

2.6

256.0

597.3

u/ml

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

355

2561

1.43

8.62

4.3

3.0

1.2

mmol/l

0.24

315

2123

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

256

1735

1.51

8.57

3.6

3.3

2.2

2.0

mmol/l

0.32

182

1296

(46235355) HIV 1 and 2 tests - Meaningful Use set

447

3360

1.37

8.53

1.7

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

310

2187

1.45

8.49

2.2

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

2969

27988

1.27

8.43

21.0

14.1

38.6

39.2

2.27

1997

18794

(3027945) Reticulocytes/100 erythrocytes in Blood

435

3263

1.38

8.41

2.5

2.2

1.8

0.15

389

2820

(3049717) Cytology report of Urine Cyto stain

146

869

1.71

8.39

2.4

1.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

359

2.11

8.39

1.7

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

598

4710

1.32

8.36

2.7

2.4

12.4

13.0

umol/l

0.86

553

4289

(3021879) Hepatitis B virus core Ab [Presence] in Serum

229

1525

1.53

8.33

1.4

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

102

549

1.88

8.22

1.9

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

108

3.07

8.11

3.1

2.3

858.4

764.4

e6/l

0.28

(40768797) Stomach Pathology biopsy report

579

4558

1.32

8.11

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

141

840

1.70

8.09

1.5

1.4

17.3

24.4

iu/ml

—

(3007461) Platelets [#/volume] in Blood

3604

34984

1.49

8.03

28.9

18.8

254.2

254.0

e9/l

0.04

3545

33896

(3037522) Nuclear Ab [Titer] in Serum

568

4471

1.32

7.95

1.4

1.3

542.6

563.5

titre

0.08

117

1007

(3000963) Hemoglobin [Mass/volume] in Blood

3605

35008

1.48

7.88

29.1

18.9

132.0

134.2

g/l

20.04

3573

34373

(3024731) MCV [Entitic volume]

3604

34998

1.48

7.86

28.8

18.7

90.9

91.2

4.28

3570

34359

(3035941) MCH [Entitic mass]

3604

35000

1.48

7.84

28.8

18.7

30.2

30.3

5.04

3569

34361

(3002179) Metamyelocytes/100 leukocytes in Blood

309

2213

1.43

7.82

4.3

3.6

1.0

0.5

0.53

356

(3026361) Erythrocytes [#/volume] in Blood

3604

35003

1.48

7.80

28.9

18.8

4.4

4.5

e12/l

6.38

3539

33777

(3010813) Leukocytes [#/volume] in Blood

3604

35006

1.48

7.77

28.9

18.8

6.9

6.6

e9/l

8.82

3540

33779

(4281824)

194

2.44

7.48

1.2

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.41

7.42

1.0

—

(3002385) Erythrocyte distribution width [Ratio]

2729

25607

1.23

7.40

23.5

15.2

13.8

13.7

5.66

2676

24953

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3176

30308

1.28

7.39

6.4

6.1

39.7

40.1

mmol/mol

1.72

2919

27873

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

3.20

7.38

1.3

1.1

18.4

30.2

0.42

(3045142) Bone marrow Pathology biopsy report

203

2.38

7.26

1.4

1.1

—

(3012501) Base excess in Blood by calculation

109

624

1.77

7.24

3.2

3.7

2.2

2.6

mmol/l

0.97

425

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

384

2896

1.36

7.17

1.6

1.5

—

(3000494) Fungus identified in Specimen by Culture

464

3601

1.33

7.16

1.5

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

389

1.97

7.15

5.0

5.1

149.7

643.1

iu/ml

1.58

(3011412) CD3 cells [#/volume] in Blood

159

2.53

6.92

2.7

2.2

1.0

1.1

e9/l

0.10

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

417

1.91

6.82

1.6

1.3

250.2

283.8

pmol/l

0.47

310

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3305

31765

1.29

6.80

5.2

4.8

5.9

mmol/l

2.49

2992

28756

(3010421) pH of Blood

123

743

1.68

6.77

3.2

3.5

7.4

0.06

108

612

(3037756) Immunofixation for Serum or Plasma

563

1.78

6.75

1.5

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

174

2.43

6.67

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

378

1.95

6.67

3.1

1.9

498.3

71.7

u/ml

0.44

337

(3026493) Urate [Moles/volume] in Serum or Plasma

953

8140

1.23

6.66

2.8

2.3

3017.2

5996.7

umol/l

1.92

806

6867

(3024354) Oxygen [Partial pressure] in Venous blood

315

2337

1.38

6.52

3.8

2.8

4.7

4.5

kpa

0.79

305

2261

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

105

616

1.72

6.45

1.6

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

105

616

1.72

6.45

1.6

1.4

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

6.13

6.43

1.4

1.2

22.0

54.2

1.54

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.21

6.41

1.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.74

6.35

3.5

2.6

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

6.68

6.31

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

185

2.34

6.31

2.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

890

7588

1.23

6.28

1.7

10249746.2

32798499.6

pmol/l

1.19

722

6165

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.17

6.28

1.0

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

382

2937

1.33

6.28

2.5

6.3

7.1

ug/l

0.38

316

2509

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

+∞

6.25

1.2

0.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

474

1.81

6.22

1.6

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

329

2478

1.36

6.20

3.1

2.3

61.8

64.1

ml/min/173m2

0.45

120

988

(3028626) Oxygen [Partial pressure] in Capillary blood

103

608

1.71

6.20

2.6

2.7

8.5

8.0

kpa

0.62

561

(3028433) Virus identified in Specimen by Culture

2.92

6.15

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

151

2.46

6.10

2.3

2.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

551

1.74

6.09

1.6

—

(3022145) Colonoscopy Study observation

416

3253

1.31

6.07

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

116

2.69

6.07

1.2

1.1

1875.0

307.3

ng/l

—

(40767503) Oxygen content in Capillary blood by calculation

102

606

1.70

6.01

2.5

2.4

15.4

16.3

1.28

317

(3034860) Kappa light chains.free [Mass/volume] in Serum

149

975

1.55

5.95

3.5

1.5

31.3

43.1

mg/l

4.50

123

793

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

256

2.09

5.90

1.6

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

321

2431

1.35

5.85

2.8

2.2

70.9

69.5

e9/l

0.31

254

1823

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.18

5.82

1.1

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

144

941

1.55

5.80

3.6

1.5

1.2

2.0

ratio

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

148

974

1.54

5.78

3.6

1.5

28.2

38.2

mg/l

0.88

122

789

(3022313) Gas panel - Capillary blood

189

1312

1.46

5.71

3.9

3.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

191

1333

1.46

5.62

3.7

24.1

24.4

mmol/l

0.71

181

1180

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

331

1.92

5.58

1.7

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

381

2979

1.31

5.57

2.5

2.9

170.7

193.5

ng/l

0.74

347

2724

(3017732) Neutrophils [#/volume] in Blood

287

2153

1.36

5.57

3.4

2.8

4.1

e9/l

0.11

204

1590

(3015235) Bicarbonate [Moles/volume] in Capillary blood

114

713

1.62

5.54

2.6

3.1

25.1

mmol/l

0.02

627

(3011397) Hemoglobin [Presence] in Urine by Test strip

902

7785

1.21

5.54

4.1

4.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

134

874

1.55

5.46

1.3

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.96

5.43

1.1

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

532

4353

1.26

5.43

25.1

27.3

1.4

inr

0.17

613

(3049242) von Willebrand panel - Platelet poor plasma

16.03

5.41

2.5

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

200

2.16

5.31

2.1

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

200

2.16

5.31

2.1

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

200

2.16

5.31

2.1

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

461

1.75

5.30

1.6

0.7

0.8

g/l

0.38

349

(3051651) Icteric interference index of Serum or Plasma

143

2.39

5.29

3.0

4.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

112

707

1.60

5.26

3.7

1.5

—

(40765096) Chromosome analysis panel by Banding

3.86

5.26

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

451

1.74

5.12

1.5

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

121

2.49

5.11

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

299

1.92

5.10

3.1

3.5

—

(3021901) Oxygen saturation in Capillary blood

512

1.70

5.09

2.3

2.7

—

(3037121) Protein [Mass/volume] in Urine

145

979

1.50

5.07

2.9

2.5

0.3

g/l

0.14

284

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

423

1.76

5.06

1.4

1.3

—

nmol/l

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.41

5.02

1.2

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.28

5.02

1.2

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

154

1056

1.48

4.99

2.0

1.7

248.9

365.0

titre

—

(21494434) Karyotype in Bone marrow

212

2.09

4.99

1.2

1.1

—

(1616796) Gas panel - Central venous blood

615

1.63

4.99

2.8

3.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

689

5850

1.22

4.97

1.5

1.3

2.3

2.4

g/l

1.64

401

3293

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

120

784

1.55

4.89

1.8

2.1

12.1

11.3

mg/l

0.18

108

711

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.00

4.82

5.1

2.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.95

4.71

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

177

1262

1.42

4.69

1.9

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

252

1.96

4.68

2.7

1.7

4256.5

1025.9

u/ml

0.36

245

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

177

1263

1.42

4.67

1.9

1.4

3.5

3.8

g/l

3.93

123

882

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

4.15

4.62

1.0

—

(3029937) Albumin [Presence] in Urine by Test strip

969

8539

1.18

4.61

5.0

4.4

0.0

estimate

1.28

350

2674

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.81

4.54

1.0

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

176

1264

1.41

4.50

1.9

1.4

7.4

7.6

g/l

0.50

127

921

(21494815) CD4 cells/100 lymphocytes in Specimen

129

2.34

4.49

1.9

2.1

41.8

46.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

161

2.18

4.49

1.1

1.3

—

(3003338) MCHC [Mass/volume]

2755

26297

1.17

4.46

24.9

16.8

331.1

331.3

g/l

0.49

2732

26102

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

105

2.49

4.45

2.4

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

105

2.49

4.45

2.4

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

105

2.49

4.45

2.4

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

105

2.49

4.45

2.4

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.77

4.44

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

175

2.13

4.43

4.1

3.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1339

12136

1.16

4.42

4.9

4.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

130

2.32

4.42

1.2

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

225

1.97

4.29

2.5

1.5

—

0.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

138

958

1.46

4.26

1.7

1.2

g/l

0.45

126

900

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.88

4.25

1.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

104

681

1.54

4.25

2.0

2.1

124.8

129.8

g/l

1.37

492

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.70

4.24

2.7

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.70

4.24

2.7

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.84

4.22

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.08

4.16

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.08

4.16

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.67

4.15

2.7

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

165

1190

1.40

4.14

1.9

1.4

3.1

g/l

0.10

123

903

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.80

4.11

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.71

4.08

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

924

8186

1.17

4.06

4.4

3.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

205

1538

1.35

4.05

3.9

2.9

25.2

25.4

mmol/l

0.43

200

1491

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.34

4.04

1.1

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

162

2.11

4.03

1.7

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

134

938

1.44

3.98

1.7

0.2

g/l

0.58

122

886

(40758292) HTLV I+II Ab panel - Serum

6.44

3.98

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

163

1182

1.40

3.98

2.0

1.4

9.4

10.3

g/l

2.33

134

964

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

282

1.82

3.97

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

137

2.20

3.95

2.0

1.9

9.6

5.0

nmol/l

0.42

111

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

191

2.00

3.92

1.6

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

742

6475

1.18

3.91

4.7

4.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.26

3.90

1.1

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

104

697

1.51

3.85

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

158

1148

1.39

3.82

4.4

3.5

25.1

mmol/l

0.04

143

1045

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

103

691

1.50

3.80

1.4

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

125

873

1.45

3.78

2.9

3.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.65

3.72

1.1

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

141

2.14

3.70

1.6

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

441

1.62

3.67

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.64

3.65

1.0

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

245

1917

1.30

3.64

3.7

3.0

127.1

129.4

g/l

1.01

240

1862

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

506

4295

1.21

3.64

4.9

4.8

33.0

33.5

0.47

351

2820

(3014148) Varicella zoster virus Ab [Titer] in Serum

255

1.81

3.58

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

368

1.67

3.55

1.6

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

118

827

1.44

3.52

1.8

4.1

4.7

iu/l

0.26

293

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1007

9067

1.15

3.50

1.6

1.4

mmol/l

0.94

867

7512

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3348

32644

1.20

3.49

5.4

5.3

2.8

mmol/l

0.12

3058

29886

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

145

1056

1.39

3.49

2.1

1.4

0.5

0.4

g/l

0.36

125

887

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

378

1.65

3.47

1.6

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

280

1.76

3.46

2.8

3.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

425

1.61

3.45

1.5

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

371

1.65

3.45

1.6

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

380

1.64

3.41

1.6

1.3

—

(40768443) Skin Pathology biopsy report

176

1328

1.34

3.40

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

373

1.65

3.39

1.4

103.8

116.3

u/ml

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

650

5680

1.17

3.35

5.9

3.9

2.7

ug/l

0.02

577

5049

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

381

3172

1.22

3.34

3.4

2.7

0.9

0.7

ug/l

1.04

277

2159

(3000093) Morphology [Interpretation] in Blood Narrative

232

1.82

3.33

1.3

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

254

1.78

3.33

1.2

1.1

—

(40761535) Cells panel - Urine sediment

347

2863

1.23

3.32

3.7

3.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

368

1.64

3.30

1.6

1.3

—

(3048879) Bone marrow aspiration report

2.62

3.30

1.9

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.47

3.29

1.2

189.5

316.8

pmol/l

1.20

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3279

31945

1.18

3.28

4.9

4.7

mmol/l

0.90

3007

29384

(4211845)

176

1.94

3.28

4.1

3.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

137

1003

1.38

3.22

1.9

1.4

37.3

37.6

g/l

0.28

115

829

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

644

1.47

3.19

2.7

2.9

1.6

mg/l

0.26

571

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.34

3.19

1.1

1.2

49.0

53.3

ng/l

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

628

1.48

3.18

1.4

1.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

388

1.61

3.16

1.6

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

128

930

1.39

3.16

1.9

1.4

0.0

g/l

1.09

115

840

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

684

6031

1.16

3.14

1.3

33.0

34.7

iu/ml

0.10

199

1921

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

119

856

1.40

3.12

2.0

1.4

0.0

g/l

0.00

107

784

(3015171) Extractable nuclear Ab [Units/volume] in Serum

180

1382

1.32

3.11

1.3

0.2

1.0

u/ml

2.49

134

(3024891) Influenza virus A+B Ag [Presence] in Specimen

682

1.45

3.08

1.3

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

5.01

3.05

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

315

1.66

3.03

1.7

1.3

32.4

33.7

u/l

0.10

234

(3000570) Elastase.pancreatic [Mass/mass] in Stool

129

946

1.38

3.03

1.5

1.4

297.0

296.8

ug/g

0.00

547

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

233

1.77

2.99

1.2

1.1

110.0

179.8

titre

—

(3006462) Nitrate [Presence] in Urine

161

1.93

2.99

4.0

3.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

120

873

1.39

2.96

1.9

1.4

0.0

g/l

0.00

107

785

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

420

1.56

2.93

1.2

8.5

3.3

u/ml

0.60

138

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

3.15

2.93

2.6

1.4

71.4

83.1

ng/l

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.83

2.91

1.1

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

334

1.63

2.91

1.7

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3250

31703

1.16

2.89

4.8

4.6

1.5

mmol/l

3.72

2955

28957

(4062490)

305

1.65

2.85

1.6

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

392

1.57

2.82

2.7

2.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

400

1.56

2.82

2.5

2.3

34.6

26.1

mg/l

0.44

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

416

1.55

2.82

1.3

1.2

3.4

5.5

u/ml

1.10

171

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

172

1.87

2.81

2.1

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

409

1.55

2.79

1.2

300.8

287.1

u/ml

0.15

246

(3025315) Body weight

4.45

2.79

6.1

4.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

117

860

1.37

2.74

5.3

4.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.20

2.73

1.1

1.2

0.7

umol/24h

0.07

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

118

2.04

2.71

1.9

2.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

125

2.01

2.70

1.7

1.3

—

(3000330) Specific gravity of Urine by Test strip

218

1755

1.26

2.65

4.5

3.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

126

1.99

2.65

1.7

1.3

—

(3045414) Leukocytes [Presence] in Urine

192

1523

1.27

2.64

2.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

183

1443

1.28

2.64

3.1

2.5

0.6

0.7

0.27

176

1377

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

2.55

2.61

1.8

1.5

13.9

48.2

u/l

0.68

(3048929) Epstein Barr virus Ab [Presence] in Serum

623

1.42

2.58

1.2

—

(40768806) Pleura Pathology biopsy report

178

1.80

2.55

1.7

1.6

—

(3022621) pH of Urine by Test strip

270

2241

1.22

2.50

3.7

3.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

123

1.96

2.45

2.0

17.0

14.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

481

1.46

2.42

1.9

1.8

5526.6

2841.6

u/l

0.37

195

(40761536) Microorganisms panel - Urine sediment

303

2553

1.20

2.41

5.2

4.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

117

1.97

2.40

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.26

2.37

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

6.26

2.37

1.0

—

(1761868) Lipid panel - Serum or Plasma

959

10418

0.89

2.36

3.1

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

3.64

2.36

1.0

1.1

—

mmol/l

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

307

1.57

2.32

1.6

1.4

2.6

2.9

g/l

0.55

213

(3024139) IgG subclass 3 [Mass/volume] in Serum

307

1.57

2.32

1.6

1.4

0.3

0.4

g/l

0.37

215

(3027135) IgG subclass 1 [Mass/volume] in Serum

308

1.57

2.29

1.6

1.4

5.9

6.7

g/l

1.28

216

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.69

2.27

1.1

1.2

1.5

1.7

umol/24h

0.47

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

4.62

2.27

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3135

30620

1.13

2.27

4.3

4.1

1.3

mmol/l

0.26

2824

27681

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

165

1313

1.27

2.26

1.7

1.6

g/l

0.09

143

1111

(21494814) CD8 cells/100 lymphocytes in Specimen

2.28

2.24

1.7

2.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

515

4562

1.15

2.23

5.0

3.8

22.4

24.1

1.87

274

2197

(4024509)

376

1.50

2.20

2.0

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

513

4550

1.15

2.19

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

328

1.53

2.19

1.7

1.3

—

(1002224) Polysomnography panel

141

1108

1.28

2.15

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

196

1.69

2.15

1.6

1.5

0.8

1.1

promille

0.46

149

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.37

2.12

2.3

2.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

382

1.47

2.06

1.6

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

269

1.57

2.05

1.4

1.2

—

(44790048)

277

1.56

2.05

1.6

1.4

—

(44806118)

277

1.56

2.05

1.6

1.4

—

(44790049)

277

1.56

2.05

1.6

1.4

—

(44790047)

277

1.56

2.05

1.6

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

110

1.91

2.05

1.5

1.1

36.6

38.3

g/l

0.28

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

441

1.44

2.03

1.7

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.64

2.01

1.6

1.2

5.9

6.2

mmol/l

—

(3047189) Immunofixation for 24 hour Urine

1.96

2.00

1.6

1.1

—

(3025941) Bacteria identified in Stool by Culture

205

1698

1.22

1.99

1.4

1.3

—

(37021550) Renin [Units/volume] in Plasma --upright

2.15

1.98

1.2

1.3

107.5

62.2

mu/l

—

(4010399)

289

2474

1.18

1.97

1.5

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.29

1.97

1.3

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

141

1.78

1.96

2.0

3.3

13.2

24.1

mu/l

2.57

136

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.36

1.95

1.2

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.75

1.93

7.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.19

1.88

1.0

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

166

1.69

1.87

11.3

11.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

252

1.55

1.86

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.65

1.86

2.6

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

122

963

1.28

1.84

1.3

33.3

47.1

u/ml

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

225

1898

1.20

1.83

2.6

2.5

—

(3036603) Volume of Urine

198

1.62

1.83

1.4

1883.4

1897.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

418

1.42

1.81

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

278

1.52

1.81

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

710

1.32

1.81

1.2

23.3

43.2

u/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

119

942

1.27

1.77

1.5

1.6

0.1

3.0

iu/ml

0.49

208

(3043410) Blood group antigens tested for on Red Blood Cells

2.06

1.70

1.4

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.96

1.69

1.1

89.8

89.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

493

1.37

1.68

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

235

1.54

1.67

2.1

2.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

118

942

1.26

1.65

1.3

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

260

1.51

1.65

3.0

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

165

1.64

1.1

1.0

ratio

—

(3042631) Mycobacterium sp identified in Specimen

344

1.43

1.61

2.2

3.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.15

1.61

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

173

2062

0.83

1.61

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

118

948

1.25

1.58

1.3

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.70

1.58

1.1

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.70

1.58

31.1

11.2

4.6

5.0

mmol/l

—

(3045424) Erythrocytes [Presence] in Urine

551

1.33

1.57

1.9

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.20

1.56

1.0

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

2.20

1.56

1.2

1.5

81.0

118.9

ug/l

—

(3012441) Differential panel - Pleural fluid

207

1.55

1.56

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.11

1.55

1.1

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.89

1.54

1.1

1.4

109.6

134.2

nmol/l

—

(3007566) Smooth muscle Ab [Titer] in Serum

102

808

1.27

1.54

1.2

40.0

178.8

titre

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.93

1.54

1.1

97.1

92.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

116

934

1.25

1.53

1.3

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

153

1.64

1.53

1.9

2.1

0.8

3.5

u/field

1.27

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

147

1215

1.22

1.53

1.7

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

257

1.48

1.52

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.34

1.52

1.0

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

459

1.36

1.52

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

627

5761

1.11

1.51

1.3

6.6

13.3

u/ml

2.38

228

2186

(3026480) Teichoate Ab [Titer] in Serum

2.60

1.51

1.1

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

100

793

1.27

1.51

2.1

2.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.16

1.50

1.3

1.7

—

(4268621)

291

1.45

1.50

2.5

2.2

—

(4306422)

418

1.37

1.49

1.2

—

(3023419) Bacteria identified in Sputum by Culture

385

1.38

1.47

2.0

2.5

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.50

1.45

2.7

1.5

—

(40768441) Liver Pathology biopsy report

148

1.63

1.44

1.5

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

180

1.56

1.42

1.6

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

517

1.32

1.42

3.1

3.4

56.7

57.5

0.20

517

(3035320) C reactive protein [Mass/volume] in Body fluid

213

1.51

1.40

2.3

2.5

—

(3019150) Specific gravity of Urine by Refractometry

772

7193

1.09

1.40

4.9

4.5

1.0

kg/l

0.09

140

1094

(3008898) HLA-B27 [Presence]

118

966

1.23

1.37

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

272

1.44

1.37

1.9

2.4

1.4

2.3

u/field

0.99

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.80

1.37

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

104

1.73

1.36

2.4

2.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

266

2339

1.15

1.36

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

758

7072

1.09

1.33

1.3

0.9

1.8

u/ml

4.73

179

1838

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.04

1.32

1.5

2.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

184

1.53

1.31

1.6

1.2

—

(3017704) Immunofixation for Urine

160

1.57

1.31

1.9

1.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.50

1.30

3.7

6.4

61.3

45.5

ug/min

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.50

1.30

2.7

1.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.36

1.29

2.5

2.9

0.4

0.8

u/field

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

114

1.67

1.28

1.1

1606.7

1666.6

miu/ml

0.06

114

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

483

1.31

1.27

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

122

1.64

1.27

1.5

2.4

200.8

144.8

umol/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

407

1.33

1.23

1.8

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.80

1.21

1.4

109.7

105.9

ng/l

0.05

(40759836) Histone Ab [Presence] in Serum by Immunoblot

238

1.43

1.20

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

479

1.30

1.20

1.8

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

118

984

1.21

1.18

1.6

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

757

1.23

1.18

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

239

1.43

1.18

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

239

1.43

1.18

1.1

1.2

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.00

1.16

0.0

1.0

—

2.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

751

1.23

1.14

3.5

3.2

0.8

nmol/l

0.57

587

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.34

1.12

1.9

2.3

—

(3048689) Calprotectin [Mass/mass] in Stool

413

3780

1.10

1.12

2.0

2.1

111.7

128.6

ug/g

0.64

309

2918

(3020491) Glucose [Moles/volume] in Blood

225

1.43

1.12

1.2

2.5

7.2

6.9

mmol/l

0.32

149

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

242

1.41

1.11

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

242

1.41

1.11

1.1

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

1.96

1.11

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

167

1447

1.16

1.09

1.4

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

495

1.28

1.09

1.4

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

243

1.40

1.09

1.1

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

160

1.50

1.09

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.95

1.08

1.9

1.8

19.8

19.0

umol/l

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

126

1068

1.19

1.08

2.0

1.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

194

2206

0.87

1.08

1.8

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.19

1.08

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

613

1.24

1.07

2.7

—

(3027008) Opiates [Presence] in Urine

515

1.27

1.06

1.8

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

516

1.26

1.05

1.8

1.6

—

(3011288) Drugs identified in Urine by Screen method

349

1.32

1.04

2.9

2.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.67

1.04

1.3

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.27

1.03

1.0

1.4

—

(36660697) Celiac disease serology panel - Serum

287

2592

1.12

1.02

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

790

1.21

1.01

1.4

1.3

—

(3024928) Oxygen saturation in Venous blood

618

1.23

1.01

3.1

3.0

—

(3028300) Cannabinoids [Presence] in Urine

520

1.25

0.99

1.8

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

214

1.41

0.99

1.3

1.6

5947.5

56497.9

e6/l

1.01

125

(4198724)

1.81

0.98

1.5

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.18

0.98

1.0

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

2.18

0.98

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.18

0.98

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.18

0.98

1.0

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

594

1.23

0.97

1.7

1.9

0.8

nmol/l

0.12

488

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.95

0.97

1.9

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.95

0.97

1.1

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

640

1.22

0.96

1.3

187.8

217.9

miu/ml

0.29

300

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.69

0.95

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

270

0.67

0.94

1.3

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

234

1.37

0.93

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

427

1.27

0.92

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.72

0.92

1.2

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.67

0.91

3.0

2.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

151

1.46

0.90

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

510

1.24

0.89

1.6

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

323

1.30

0.89

1.4

1.2

59.3

58.4

u/l

0.04

223

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.07

0.89

2.3

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.07

0.89

1.8

2.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

254

1.34

0.88

1.0

782.9

711.7

ng/l

0.29

157

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.79

0.87

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

169

1.42

0.87

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

217

0.64

0.87

1.4

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.00

0.87

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

120

1.50

0.85

1.1

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

120

1.50

0.85

1.1

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.94

0.84

2.0

2.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

316

2903

1.10

0.84

1.6

1.4

0.01

268

2524

(3000492) Spirometry study

305

2798

1.10

0.84

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

105

901

1.17

0.83

1.3

14.3

5.5

u/ml

0.47

155

(3006653) Thiamine [Moles/volume] in Blood

154

1.43

0.83

1.2

1.3

133.6

135.6

nmol/l

0.12

154

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

257

1.33

0.83

1.0

33.2

47.0

ng/l

1.46

162

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

240

1.34

0.82

1.1

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

102

1185

0.86

0.81

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

418

1.25

0.80

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

122

1.48

0.80

1.2

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

224

0.67

0.80

1.4

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

130

1480

0.87

0.79

1.4

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.77

0.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

103

890

1.16

0.76

1.3

2.1

5.5

u/ml

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.77

0.76

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.77

0.76

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.77

0.76

1.0

—

(3044007) Cell count panel - Peritoneal fluid

1.70

0.75

1.4

2.8

—

(3035933) Granulocytes/100 leukocytes in Blood

1.70

0.75

1.6

2.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.70

0.75

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

155

1380

1.13

0.75

1.4

1.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.64

0.75

1.2

—

288.0

titre

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

192

1.36

0.75

1.5

2.4

9.6

u/l

2.18

(3002523) Influenza virus A Ag [Presence] in Specimen

324

1.27

0.74

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.08

0.74

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

255

0.70

0.74

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

255

0.70

0.74

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

254

0.71

0.73

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

254

0.71

0.73

1.3

1.4

—

(40768446) Kidney Pathology biopsy report

1.52

0.72

2.3

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

416

1.23

0.71

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

294

1.26

0.66

1.4

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

214

0.70

0.66

1.3

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

1081

10452

1.05

0.65

3.1

6.8

mmol/l

0.23

902

8691

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

154

1.37

0.65

1.3

—

(3005033) Fetal Nuchal fold Thickness US

213

0.70

0.64

1.3

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

251

1.28

0.64

1.0

329.5

343.4

ng/l

0.08

163

(3003740) Influenza virus B Ag [Presence] in Specimen

323

1.24

0.63

1.0

1.1

—

(3045716) Anion gap in Serum or Plasma

155

1.36

0.63

2.2

2.0

8.5

9.5

mmol/l

1.00

119

(3004775) Volume in Urine collected for unspecified duration

243

1.28

0.62

1.9

2.3

639.6

609.3

0.17

163

(44806420)

104

1.44

0.62

2.7

2.3

—

(3045788) Cell count panel - Pleural fluid

199

1.31

0.62

1.4

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

147

1.36

0.61

1.1

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

1.67

0.61

1.6

2.4

15.5

15.7

ml/dl

—

(3023199) Leukocytes [#/volume] in Pleural fluid

244

1.27

0.61

1.3

1.6

1650.4

2339.2

e6/l

0.46

176

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.60

0.0

1.5

—

(3016750) Collection duration of Urine

165

1.34

0.60

1.7

2.1

476.3

500.7

min

0.51

126

(3012516) Albumin [Mass/volume] in Urine

1043

10096

1.05

0.60

3.1

3.2

544.1

332.3

mg/l

0.56

630

6005

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.50

0.59

2.0

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

742

1.15

0.59

1.8

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

473

1.19

0.59

1.5

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

529

1.17

0.58

1.8

1.6

—

(3020650) Glucose [Presence] in Urine

1.48

0.57

1.2

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.48

0.57

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

234

2169

1.08

0.57

1.2

164.7

138.8

iu/ml

0.44

842

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.67

0.56

2.7

2.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.67

0.56

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

115

1.39

0.56

2.1

1.6

0.5

0.4

ug/l

0.20

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.58

0.56

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

869

0.87

0.55

1.6

1.8

—

(3000012) Reticulocyte production index

159

1.32

0.55

1.8

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

321

1.22

0.54

1.1

1.0

2.3

u/ml

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1097

10658

1.04

0.53

3.8

3.9

8.1

7.3

mg/mmol

0.18

659

6367

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.49

0.53

2.0

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

169

1.30

0.53

1.2

173.2

271.3

u/l

0.69

154

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1065

0.89

0.52

1.8

1.7

3.5

3.6

mg/l

0.05

768

(3039443) Prostate specific Ag panel - Serum or Plasma

259

0.77

0.51

1.4

1.7

—

(44813793)

215

1.26

0.50

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

118

1.36

0.50

1.3

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

417

1.18

0.49

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

465

0.84

0.49

1.4

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

110

1.37

0.48

1.0

1.1

—

(3019977) pH of Arterial blood

154

1.30

0.48

1.5

2.6

7.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.52

0.48

1.1

1.3

—

(3005570) Glucose [Moles/volume] in Urine

363

1.19

0.48

2.0

2.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

172

1.28

0.48

1.1

1.4

—

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

308

1.20

0.48

1.5

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

128

1.33

0.47

1.7

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

128

1.33

0.47

1.7

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

457

1.16

0.47

2.0

1.5

63.4

60.6

0.23

277

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

218

1.24

0.46

1.5

0.9

1.0

g/l

0.18

218

(3028679) Herpes simplex virus Ab [Presence] in Serum

120

1.33

0.46

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

219

1.23

0.45

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

779

0.88

0.44

2.1

2.3

70.4

86.4

ug/min

0.19

455

(3000034) Microalbumin [Mass/volume] in Urine

320

1.19

0.44

3.2

2.9

21.8

18.9

mg/l

0.11

227

(3036071) Salmonella sp Ab [Titer] in Serum

1.40

0.44

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

130

1.31

0.43

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

489

1.15

0.43

1.4

1.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

130

0.69

0.43

8.7

12.6

1020.6

800.0

nmol/l

—

124

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.61

0.43

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

360

0.83

0.42

1.1

1.6

1.5

g/l

0.66

311

(3019174) dRVVT (LA screen)

1.56

0.42

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.56

0.42

1.2

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

206

1930

1.07

0.42

1.3

174.2

201.1

u/ml

0.22

187

1773

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

158

1.27

0.41

1.2

1.1

31.0

22.2

u/l

0.34

108

(3024932) HLA-DR beta [Type]

1.38

0.41

1.3

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.38

0.41

2.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

105

1.33

0.41

1.0

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

183

0.76

0.40

1.5

1.7

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.47

0.40

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

132

1.29

0.40

1.0

0.2

1.1

u/ml

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

159

1.26

0.40

1.2

1.1

83.0

80.3

u/l

0.06

113

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.1

—

(3024471) HLA-A [Type]

1.31

0.39

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.39

0.0

2.6

—

(3044927) Protein electrophoresis panel - Urine

363

1.16

0.38

1.3

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

429

1.14

0.38

1.1

1.3

40.9

45.7

u/ml

—

(3037556) Urate [Mass/volume] in Serum or Plasma

113

0.71

0.37

1.0

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

161

1.24

0.37

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

125

1.28

0.37

3.6

4.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.66

0.35

4.0

3.1

3.3

6.8

mg/l

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

162

1.24

0.35

1.0

—

(3006270) Folate [Moles/volume] in Blood

312

1.16

0.33

1.1

1.2

338.9

374.2

nmol/l

0.48

261

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

182

1.21

0.33

1.6

1.2

19.4

17.1

u/l

0.18

157

(3044242) Glucose [Moles/volume] in Arterial blood

146

1.23

0.32

1.4

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.32

0.30

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.30

0.30

1.3

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

184

1744

1.06

0.30

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

1.29

0.30

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

162

1530

1.06

0.29

1.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.25

0.29

2.4

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.25

0.29

1.1

1.8

—

(3002619) Bacteria identified in Specimen by Culture

1.25

0.29

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

269

1.15

0.29

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

101

939

1.08

0.29

1.8

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

158

1.20

0.28

1.0

—

(40757373) Influenza virus identified in Isolate

1.29

0.28

2.6

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

403

1.12

0.27

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

1.30

0.26

1.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

188

1.17

0.25

1.6

1.2

84.7

79.5

u/l

0.17

165

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

172

1639

1.05

0.25

1.1

—

(3011648) Oxygen content in Venous blood

234

0.85

0.24

1.7

2.0

11.8

10.8

0.44

234

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

321

1.12

0.24

1.7

1.4

21.1

33.4

1.50

191

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

436

1.10

0.24

1.1

0.7

1.1

u/ml

0.37

166

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

842

1.07

0.23

1.0

1.1

2.4

6.9

u/ml

—

(4146454)

391

0.89

0.23

3.2

2.6

—

(3004616) Nuclear Ab [Presence] in Serum

437

1.10

0.23

1.4

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

147

0.82

0.23

1.4

1.5

—

(4094501)

911

1.07

0.23

1.1

—

(44806071)

1.32

0.23

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

209

1.15

0.22

1.3

1.2

—

(3004451) EKG impression Narrative

153

1.18

0.22

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

210

2019

1.04

0.22

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

242

0.87

0.22

1.0

1.2

0.0

1.1

u/ml

—

113

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.22

0.22

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

294

0.88

0.21

2.3

1.7

29.2

21.2

u/ml

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

3.7

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

4.9

—

338.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

219

0.87

0.20

1.1

1.3

9.3

11.6

mmol/l

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

364

1.10

0.20

1.1

0.9

0.8

u/ml

0.08

148

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

327

3363

0.97

0.20

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

174

1.15

0.19

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.18

0.19

1.0

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

375

1.09

0.19

1.0

1.1

1.8

3.7

u/ml

1.08

182

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

375

1.09

0.19

1.0

1.1

3.5

3.0

u/ml

0.11

153

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

374

0.91

0.18

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.24

0.18

1.4

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.24

0.18

1.4

2.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

378

1.09

0.17

1.1

1.2

7.7

7.6

mmol/l

0.08

271

(3045683) HLA typing for celiac disease panel - Blood or Tissue

167

1.14

0.16

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

263

1.10

0.16

1.1

6.6

3.2

u/ml

—

105

(3000475) Leukocytes [#/volume] in Synovial fluid

874

0.95

0.16

2.1

1.5

8777.4

11549.8

e6/l

0.72

624

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.20

0.16

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.20

0.16

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.20

0.16

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.20

0.16

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

339

0.91

0.16

1.7

1.3

20049.4

118647.7

e6/l

1.83

222

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1026

0.95

0.16

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

1.10

0.15

2.8

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

207

1.11

0.15

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.81

0.13

1.5

1.4

11.1

8.9

ug/l

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

482

1.06

0.12

1.1

1.2

34.3

24.7

u/l

0.47

417

(3050129) First trimester maternal screen panel - Serum or Plasma

303

0.92

0.12

1.4

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

929

1.03

0.10

1.9

1.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

136

1392

0.98

0.08

2.1

1.8

—

(3015183) Erythrocyte sedimentation rate

117

1.11

0.08

1.1

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.09

0.08

1.1

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

713

0.97

0.07

3.1

3.5

30.1

25.0

mg/l

0.35

450

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.84

0.07

1.0

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

0.83

0.07

5.2

6.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.81

0.07

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

439

0.96

0.07

1.2

1.1

13.9

26116.4

iu/ml

—

(3025130) Human papilloma virus identified in Specimen

398

0.95

0.07

1.3

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.87

0.06

1.1

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

102

0.88

0.06

1.3

1.5

—

(3034426) Prothrombin time (PT)

103

0.87

0.06

1.8

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

546

5498

0.99

0.05

1.4

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

110

0.91

0.05

1.2

1.3

59.0

48.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

289

1.04

0.04

1.0

1.1

9.8

3.2

u/ml

—

110

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

121

1.07

0.03

2.4

1.1

2.6

ug/l

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

159

0.94

0.03

1.1

1.3

—

(4034850)

118

1166

1.01

0.03

8.3

9.8

—

(3021788) Differential panel - Synovial fluid

639

1.02

0.02

2.1

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

152

1.05

0.02

1.0

1.1

—

(3035880) pH of Pleural fluid

105

0.95

0.00

1.8

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

161

0.99

0.00

1.3

1.2

—

(3024263) Appearance of Synovial fluid

179

1.01

0.00

2.0

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.04

0.00

1.0

1.1

—

(4015189)

1.04

0.00

5.0

2.5

—

(3022689) Creatine [Moles/volume] in Urine

104

0.96

0.00

1.1

1.5

—

(3044941) Cell count panel - Synovial fluid

557

1.01

0.00

1.7

1.4

—

(3017569) Oxygen content in Arterial blood

153

0.98

0.00

1.7

2.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.2

—

(3042733) HLA Ab [Presence] in Serum

0.98

0.00

3.2

4.8

—

(3052592) Norovirus Ag [Presence] in Stool

1.00

0.00

1.7

1.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

2.4

—

(3018133) Calcium [Moles/volume] in Urine

1.02

0.00

2.6

1.7

2.9

mmol/l

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.9

—

1.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.6

—

2.4

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3013762) Body weight Measured

0.00

0.0

1.6

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(4133840)

0.97

0.00

1.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

1.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.94

0.00

3.2

1.8

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

4.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_MENINGES_EXALLC – Benign neoplasm of meninges

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign neoplasm of meninges

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints